DGFT Committee Minutes
UDIN00236046AM23
Government of India Ministry of Commerce and Industry Department of Commerce
DIRECTORATE GENERAL OF FOREIGN TRADE
(DES - III SECTION)
MINUTES OF THE NORMS COMMITTEE- III
MEETING No. NC/3/MEET/Sep/202223/9 DATED: 07/10/2022
Please Note
-
I. For information of exporters, Norms Committee - III handles all cases pertaining to fixation/ratification of norms for Export Products falling under ITC (HS) Chapter 29, 30 .Communications in respect of cases/pertaining to NC- III may be sent to email address: nc3.dgft@nic.in
-
II. The Norms Committee has taken decision only with respect to technical aspect/wastage norms. While redeeming the applications, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure including those in Policy Circulars issued from time to time or any other provisions under FTP/HBP for EODC.
-
III. Wherever the Committee has fixed Norms, the concerned RA may ensure that AA is issued on the wastages/consumption as ratified by the Committee or as per wastages claimed in the application, whichever is less.
Meeting No. NC/3/MEET/Sep/202223/9 dated 07/10/2022 of Norms Committee - III for the year 2022-23 was held on 07/10/2022 under the Chairmanship of Rajiv Soni ,Joint DGFT to consider the following applications for ratification of norms in respect of advance authorizations under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy 2015-20.
The following members were present in the meeting:-
| S.No. | Name and Designation of Representatives | Department | |
|---|---|---|---|
| 1 | AJAY KUMAR,Deputy Director | Directorate General of Foreign Trade, Delhi | |
| 2 | SHAISH KUMAR,Technical Authority | Technical Consultant,DGFT | |
| 3 | DINESHNARAIN MATHUR,Technical<br>Authority | Technical Consultant,DGFT |
Case Details and Decision(s):
| Case No. | 1 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
Signature Not Verified Signature Not Verified Digitally Signed. Digitally signe Name: Ajay Kumar( Deputy Director ) Name: Ajay Kumar( uty Director ) Date: 19-Oct-2022 12:55:42 Date: 19-Oct-2022 2:55:42 Reason: AJAY.DHIMAN88@GOV.IN Reason: AJAY. IAN88@GOV.IN Location: DGFT(HQ) Location: DGFTIHG)
This document has been digitally signed by AJAY KUMAR, Deputy Director,DGFT(HQ) on 19-Oct-2022.
1
UDIN00236046AM23
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||
|---|---|---|---|
| HQ File Number<br>HQRNORM APPLY 00041071AM22 | |||
| RA File Number<br>NA | |||
| Licence No and<br>Date<br>NA | |||
| Norms Committee Decision: | |||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||
| or as applied by the firm, whichever is less: | |||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. | |
| 1<br>Ciprofloxacin<br>Hydrochloride<br>1 kg | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||
| 2 | Piperazine Anhydrous | 0.390 kg | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 2 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | CORPORATE CHANNELS (INDIA) PVT. LTD |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00002028AM23 |
| RA File Number | 132404000019 AM14 |
| Licence No and<br>Date | 1310044179/29/08/2013 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No. | 3 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | KAIRAV CHEMOFARBE INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00160014AM22 |
| RA File Number | 039404000859 AM16 |
| Licence No and | 0310802380/09/02/2016 |
Signature Not Verified
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
2
UDIN00236046AM23
Date
Norms Committee Decision:
The Committee considered the request of firm for review of adhoc norms and it was observed that the firm has not provided the purity in the description of Export Product and Import Item. Hence, the Committee decided to reject the case maintaining the status quo.
RA concerned may take further necessary action as per above decision of NC.
| Case No. | 4 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | PARAMOUNT AROMACHEM PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00001869AM23 |
| RA File Number | 052404000399 AM17 |
| Licence No and<br>Date | 0510400599/02/12/2016 |
| Norms Committee Decision: | |
| The Committee considered the request of firm for review of adhoc norms and it was decided to call for following | |
| information/documents from the firm: | |
| COA of import and export item.<br>i. | |
| Stoichiometric balance on molar basis and yield to arrive at the quantity of raw material obtained.<br>ii. | |
| Technical literature in support of its claim.<br>iii. | |
| iv Production | / Consumption data for the period 2017-18 duly certified by GST. |
| Case No. | 5 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | PARAMOUNT AROMACHEM PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00001867AM23 |
| RA File Number | 052404000008 AM18 |
| Licence No and<br>Date | 0510402246/18/04/2017 |
| Norms Committee Decision: | |
| The Committee considered the request of firm for review of adhoc norms and it was decided to call for following | |
| information/documents from the firm: | |
| COA of import and export item.<br>i. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
3
UDIN00236046AM23
-
ii. Stoichiometric balance on molar basis and yield to arrive at the quantity of raw material obtained.
-
iii. Technical literature in support of its claim.
iv Production / Consumption data for the period 2017-18 duly certified by GST.
| Case No. | 6 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | PARAMOUNT AROMACHEM PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00001870AM23 |
| RA File Number | 052404000297 AM18 |
| Licence No and<br>Date | 0510404439/31/10/2017 |
| Norms Committee Decision:<br>The Committee considered the request of firm for review of adhoc norms and it was decided to call for following<br>information/documents from the firm:<br>COA of import and export item.<br>i.<br>Stoichiometric balance on molar basis and yield to arrive at the quantity of raw material obtained.<br>ii.<br>Technical literature in support of its claim.<br>iii.<br>iv Production / Consumption data for the period 2017-18 duly certified by GST. |
| Case No. | 7 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | KAIRAV CHEMOFARBE INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00160008AM22 |
| RA File Number | 039404000838 AM18 |
| Licence No and<br>Date | 0310818810/31/01/2018 |
| Norms Committee Decision:<br>The Committee considered the request of firm for review of adhoc norms and it was decided to call for following<br>information/documents from the firm:<br>Copy of Shipping Bills indicating percentage purity of export product.<br>i.<br>ii Copy of Bill of Entry indicating percentage purity of import item. |
| Case No. | 8 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
4
UDIN00236046AM23
| Party Name | TIDE INDUSTRIES |
|---|---|
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000196AM23 |
| RA File Number | 342404000094 AM19 |
| Licence No and<br>Date | 3410044399/08/08/2018 |
| Norms Committee Decision:<br>The Committee considered the request of firm for review of adhoc norms and it was decided to call for following<br>information/documents from the firm:<br>Any Published Literature to indicate low yield of 70% in such type of process. |
| Case No. | 9 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SYNNAT PHARMA PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000444AM23 |
| RA File Number | 022404000044 AM20 |
| Licence No and<br>Date | 0210209260/17/06/2019 |
| Norms Committee Decision:<br>The Committee considered the request of firm for review of adhoc norms and taking cue from earlier decision for<br>same export product / import item in Meeting No.NC/3/MEET/Aug/202223/6 dated 09.09.2022against advance<br>authorization No.0210208260 dated 07.03.2018, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol.<br>I as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>Noscapine BP USP Ph.Eur JP CP / Noscapine<br>Hydrochloride BP Ph.Eur<br>1 kg<br>1<br>Noscapine Crude Content 95%<br>1.158 kg<br> <br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 10 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | VN CREATIVE CHEMICALS PRIVATE LIMITED |
| Meeting Number | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
Signature Not Verified
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
5
UDIN00236046AM23
| and Date | |||||
|---|---|---|---|---|---|
| HQ File Number | HQRNORM REVIW00001314AM23 | ||||
| RA File Number | 039504000232 AM20 | ||||
| Licence No and<br>Date | 0310829915/25/06/2019 | ||||
| Norms Committee Decision: | |||||
| The Committee considered the request of firm for review of adhoc norms and it was decided to revise adhoc norms as | |||||
| under: | |||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | ||
| Tonalid | 1 kg | 1 | D M B-1 (2, 3 Dimethyl 1 Butene) | 0.896 kg | |
| 2 | Paracymene | 0.750 kg | |||
| RA concerned may take further necessary | action as per | above decision of NC. |
| Case No.<br>11 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>SYNNAT PHARMA PRIVATE LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>HQRNORM REVIW00000446AM23 | ||||
| RA File Number<br>022404000056 AM20 | ||||
| Licence No and<br>Date<br>0210209307/12/07/2019 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the request of firm for review of adhoc norms and taking cue from earlier decision for | ||||
| same export product / import item in Meeting No.NC/3/MEET/Aug/202223/6 dated 09.09.2022against advance | ||||
| authorization No.0210208260 dated 07.03.2018, it was decided to ratify adhoc norms under Para | 4.07 of HBP Vol. | |||
| I as per details given below or as applied by the firm, whichever is | less: | |||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. | ||
| Noscapine BP USP Ph.Eur JP CP / Noscapine<br>1 kg<br>1 | Noscapine Crude Content 95% | 1.158 kg | ||
| Hydrochloride BP Ph.Eur |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
6
UDIN00236046AM23
| Case No. | Case No. | 12 / NC/3/MEET/Sep/202223/9 | 12 / NC/3/MEET/Sep/202223/9 | 12 / NC/3/MEET/Sep/202223/9 | 12 / NC/3/MEET/Sep/202223/9 | 12 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | VN CREATIVE CHEMICALS PRIVATE LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM REVIW00001316AM23 | |||||
| RA File Number | 039504000497 AM20 | |||||
| Licence No and<br>Date | 0310831036/16/08/2019 | |||||
| Norms Committee Decision:<br>The Committee considered the request of<br>under: | firm for review of adhoc norms and it was decided to revise adhoc norms as | |||||
| Export produ | ct | Qty. | Sl. No. | Import items | Qty. | |
| Tonalid | 1 k | 1 | D M B-1 (2 3 Dimethl 1 Butene) | 0896 k | ||
| g | , y | . g | ||||
| 2 | Paracymene | 0.750 kg | ||||
| RA concerned may take further necessary action as per above decision of NC. | ||||||
| Case No. | 13 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Approved | |||||
| Party Name | VN CREATIVE CHEMICALS PRIVATE LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM REVIW00001317AM23 | |||||
| RA File Number | 039504000551 AM20 | |||||
| Licence No and | 0310831364/04/09/2019 | |||||
| Date | ||||||
| Norms Committee<br> | Decision:<br> | |||||
| The Committee co<br>under: | nsidered the request of firm for review of adhoc norms and it was decided to revise adhoc norms as | |||||
| Case No. | 13 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | VN CREATIVE CHEMICALS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00001317AM23 |
| RA File Number | 039504000551 AM20 |
| Licence No and<br>Date | 0310831364/04/09/2019 |
| Norms Committee Decision: | |
| The Committee considered the request of firm for review of adhoc norms and it was decided to revise adhoc norms as | |
| under: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
7
UDIN00236046AM23
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Tonalid | 1 kg | 1 | D M B-1 (2, 3 Dimethyl 1 Butene) | 0.896 kg |
| 2 | Paracymene | 0.750 kg |
| Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>1<br>D M B-1 (2, 3 Dimethyl 1 Butene)<br>0.896 kg<br>Tonalid<br>1 kg<br>2<br>Paracymene<br>0.750 kg<br> | Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>1<br>D M B-1 (2, 3 Dimethyl 1 Butene)<br>0.896 kg<br>Tonalid<br>1 kg<br>2<br>Paracymene<br>0.750 kg<br> | Export product | Export product | Qty. | Sl. No. | Sl. No. | Sl. No. | Import items | Import items | Qty. |
|---|---|---|---|---|---|---|---|---|---|---|
| Tonalid | 1 kg | 1 | D M B-1 (2, 3 Dimethyl 1 Butene) | 0.896 kg | ||||||
| 2 | Paracymene | 0.750 kg | ||||||||
| RA concerned may take further necessary action as per above decision of NC. | ||||||||||
| Case No. | 14 / NC/3/MEET/Sep/202223/9 | |||||||||
| Case Status | Case Approved | |||||||||
| Party Name | PANACEA BIOTEC LIMITED | |||||||||
| Mti Nb | ||||||||||
| eeng umer<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||
| HQ File Number | HQRNORM REVIW00001880AM23 | |||||||||
| RA File Number | 052404000410 AM20 | |||||||||
| Li N d | ||||||||||
| cence o an<br>Date | 0510412195/21/10/2019 | |||||||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Aug/202223/6 dated 09.09.2022against advance authorization No.<br>0510413419 dated 22.01.2020, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details<br>given below or as applied by the firm, whichever is less:<br> <br> <br> <br> <br> | ||||||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||||||
| Easy Five TT | Vaccine | <br>1<br>Million | 1<br> | Purified Diptheria Toxoid Concentrate | 13.33 Litre | |||||
| DTwP-Hep | B-Hib- | Vials | Antigen Bulk @2050 Lf/ml | |||||||
| Pentavalent Vac<br>vial of 0.5 ml<br> | cine (Each<br>contains 1 | <br> | ||||||||
| 2 | Purified Tetanus Toxoid Concentrate | 523 Litre | ||||||||
| dose) | <br>Antigen @1900 Lf/ml | . | ||||||||
| 3 | Inactivated Whole Cell Pertussis Bulk<br> | <br>86.46 Litre | ||||||||
| @192 OU/ml | ||||||||||
| 4 | Rubber Stopper | 1010000 Numbers | ||||||||
| 5 | AGS HB Purification MABS Column | 5.4 Litre | ||||||||
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
8
UDIN00236046AM23
6 Tetanus Toxoid for conjugation 6.15 Litre
| Case No. | 15 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | YASHO INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000521AM23 |
| RA File Number | 039504000760 AM20 |
| Licence No and<br>Date | 0310832692/11/11/2019 |
| Norms Committee Decision: | |
| The Committee considered the request of firm for review of adhoc norms and it was observed that at the time of filing | |
| application, the consumption shown in Appendix 4E is 0.665 kg and 1.107 kg, however now while | |
| filing review, the consumption shown in Appendix 4E is 0.735 kg and 1.232 kg. Furthermore, no justification has | |
| been provided for enhancement of norms. | |
| Hence, the Committee decided torejectthe case maintaining the status quo. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No.<br>16 / NC/3/MEET/Sep/202223/9 | Case No.<br>16 / NC/3/MEET/Sep/202223/9 | |||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>VN CREATIVE CHEMICALS PRIVATE LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ | File Number<br>HQRNORM REVIW00001320AM23 | |||
| RA File Number<br>039504000849 AM20 | ||||
| Licence No and<br>Date<br>0310833213/04/12/2019 | ||||
| Norms Committee Decision: | ||||
| The | Committee considered the request of firm for fixation of adhoc norms and it was decided to | ratify adhoc norms | ||
| under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
9
UDIN00236046AM23
| Tonalid | 1 | kg | 1 | D M B-1 (2, 3 Dimethyl 1 Butene) | 0.896 kg |
|---|---|---|---|---|---|
| 2 | Paracymene | 0.750 kg |
| Case No. | Case No. | Case No. | 17 / NC/3/MEET/Sep/202223/9 | 17 / NC/3/MEET/Sep/202223/9 | 17 / NC/3/MEET/Sep/202223/9 | 17 / NC/3/MEET/Sep/202223/9 | 17 / NC/3/MEET/Sep/202223/9 | 17 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||||
| Party Name | SYNNAT PHARMA PRIVATE LIMITED | |||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||
| HQ File Number | HQRNORM REVIW00000385AM23 | |||||||
| RA File Number | 022404000012 AM21 | |||||||
| Licence No and<br>Date | 0210209889/29/05/2020 | |||||||
| Norms Committee Decision:<br>The Committee considered the request of firm for review of adhoc norms and taking cue from earlier decision for<br>same export product / import item in Meeting No.NC/3/MEET/Aug/202223/6 dated 09.09.2022against advance<br>authorization No.0210208260 dated 07.03.2018, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol.<br>I as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>Noscapine BP USP Ph.Eur JP CP / Noscapine<br>Hydrochloride BP Ph.Eur<br>1 kg<br>1<br>Noscapine Crude Content 95%<br>1.158 kg<br> | ||||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||||
| Noscapine BP USP Ph.Eur JP CP / Noscapine<br>Hydrochloride BP Ph.Eur | <br>1 kg | 1 | Noscapine Crude Content 95% | 1.158 kg | ||||
| RA concern | ed may take further necessary action as per above dec | ision of NC. | ||||||
| Case No | 18 / NC/3/MEET/Sep/202223/9 | |||||||
| . | ||||||||
| Case Status | Case Approved | |||||||
| Party Name | SYNNAT PHARMA PRIVATE LIMITED | |||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||
| HQ File Number | HQRNORM REVIW00000388AM23 | |||||||
| RA File Number | 022404000050 AM21 | |||||||
| Licence No and<br> | 0210210010/27/07/2020 | |||||||
| Date | ||||||||
| Case No. | 18 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SYNNAT PHARMA PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000388AM23 |
| RA File Number | 022404000050 AM21 |
| Licence No and<br>Date | 0210210010/27/07/2020 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
10
UDIN00236046AM23
Norms Committee Decision:
The Committee considered the request of firm for review of adhoc norms and taking cue from earlier decision for same export product / import item in Meeting No. NC/3/MEET/Aug/202223/6 dated 09.09.2022 against advance authorization No. 0210208260 dated 07.03.2018 , it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Noscapine BP USP Ph.Eur JP CP / Noscapine<br>Hydrochloride BP Ph.Eur | <br>1 kg | 1 | Noscapine Crude Content 95% | 1.158 kg |
| Case No. | 19 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | KUSUMA PHARMA |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00002033AM23 |
| RA File Number | 039404000198 AM21 |
| Licence No and<br>Date | 0310837494/29/07/2020 |
| Norms Committee Decision:<br>The Committee considered the request of firm for review of adhoc norms and it was observed that the firm has not<br>given any technical details in support of its request.<br>In view of above, the Committee decided torejectthe case maintain the status quo.<br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 20 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | KUSUMA PHARMA |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00002036AM23 |
| RA File Number | 039404000356 AM21 |
| Licence No and<br>Date | 0310837963/28/08/2020 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
11
UDIN00236046AM23
The Committee considered the request of firm for review of adhoc norms and it was observed that the firm has not given any technical details in support of its request.
In view of above, the Committee decided to reject the case maintain the status quo.
| Case No. | 21 / NC/3/MEET/Sep/202223/9 | ||
|---|---|---|---|
| Case Status | Case Approved | ||
| Party Name | VN CREATIVE CHEMICALS PRIVATE LIMITED | ||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||
| HQ File Number | HQRNORM REVIW00001315AM23 | ||
| RA File Number | 039504000298 AM21 | ||
| Licence No and<br>Date | 0310838023/01/09/2020 | ||
| Norms Committee Decision: | |||
| The Committee considered the request of firm for review of adhoc norms and it was decided to revise adhoc norms as | |||
| under: | |||
| Export product<br>Qty.<br>Sl. No.<br>Import items | Qty. | ||
| Tonalid | 1<br>D M B-1 (2, 3 Dimethyl 1 Butene)<br>1 kg | 0.896 kg | |
| 2<br>Paracymene | 0.750 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 22 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | STERILE INDIA PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000568AM23 |
| RA File Number | 052404000295 AM21 |
| Licence No and<br>Date | 0510415273/21/09/2020 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
12
UDIN00236046AM23
The Committee considered the request of firm for fixation of adhoc norms and it was decided to call for following information/documents from the firm:
i. DML.
- ii. Master Batch Formula .
iii. COA of import item from foreign supplier.
| Case No. | Case No. | 23 / NC/3/MEET/Sep/202223/9 | 23 / NC/3/MEET/Sep/202223/9 | 23 / NC/3/MEET/Sep/202223/9 | 23 / NC/3/MEET/Sep/202223/9 | 23 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001749AM21 | |||||
| RA File Number | 039404001019 AM20 | |||||
| Licence No and<br>Date | 0310838949/16/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 24 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | 018205001750AM21 |
| RA File Number | 039404000978 AM20 |
| Licence No and<br>Date | 0310838950/16/10/2020 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
13
UDIN00236046AM23
Norms Committee Decision:
The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. | |
|---|---|---|---|---|---|
| Ciprofloxacin | Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | 25 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001751AM21 | |||||
| RA File Number | 039404000297 AM21 | |||||
| Licence No and<br>Date | 0310838951/16/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>d f h fi i didd if dh d P 407 f HBP Vl I dil i bl | ||||||
| ata rom oter rms, t was ece to raty aoc norms uner ara . o o. as per etas gven eow<br>lid b th fi hih i l | ||||||
| r as appe y | rm, wcever s ess: | |||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br> | Hydrochloride<br> | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br> | 1.240 kg | |
| BP/EP/USP (Cip | rofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
14
UDIN00236046AM23
| Case No. | Case No. | 26 / NC/3/MEET/Sep/202223/9 | 26 / NC/3/MEET/Sep/202223/9 | 26 / NC/3/MEET/Sep/202223/9 | 26 / NC/3/MEET/Sep/202223/9 | 26 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001753AM21 | |||||
| RA File Number | 039404000524 AM21 | |||||
| Licence No and<br>Date | 0310838953/16/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 27 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | 018205001755AM21 |
| RA File Number | 039404000184 AM21 |
| Licence No and<br>Date | 0310838958/16/10/2020 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
15
UDIN00236046AM23
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg |
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 28 / NC/3/MEET/Sep/202223/9 | 28 / NC/3/MEET/Sep/202223/9 | 28 / NC/3/MEET/Sep/202223/9 | 28 / NC/3/MEET/Sep/202223/9 | 28 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001745AM21 | |||||
| RA File Number | 039404000392 AM21 | |||||
| Licence No and<br>Date | 0310838931/16/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 29 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
16
UDIN00236046AM23
| Party Name | Party Name | AARTI DRUGS LIMITED | AARTI DRUGS LIMITED | AARTI DRUGS LIMITED | AARTI DRUGS LIMITED | AARTI DRUGS LIMITED |
|---|---|---|---|---|---|---|
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001746AM21 | |||||
| RA File Number | 039404000516 AM21 | |||||
| Licence No and<br>Date | 0310838932/16/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | Case No. | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001758AM21 | |||||
| RA File Number | 039404000525 AM21 | |||||
| Licence No and<br>Date | 0310838974/19/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. |
| Case No. | Case No. | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 | 30 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001758AM21 | |||||
| RA File Number | 039404000525 AM21 | |||||
| Licence No and<br>Date | 0310838974/19/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
17
UDIN00236046AM23
| Ciprofloxacin | Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
|---|---|---|---|---|---|
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg |
RA concerned may take further necessary action as per above decision of NC
| Case No.<br>31 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>018205001759AM21 | ||||
| RA File Number<br>039404000528 AM21 | ||||
| Licence No and<br>Date<br>0310838975/19/10/2020 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 32 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | 018205001767AM21 |
| RA File Number | 039404000526 AM21 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
18
UDIN00236046AM23
| Licence No and<br>Date<br>0310839001/20/10/2020 | |||
|---|---|---|---|
| Norms Committee Decision: | |||
| The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||
| or as applied by the firm, whichever is less: | |||
| Export product<br>Qty. | Sl. No. Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||
| 2<br>Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No.<br>33 / NC/3/MEET/Sep/202223/9 | Case No.<br>33 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|---|
| Case Status<br>Case Approved | |||||
| Party Name<br>AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number<br>018205001769AM21 | |||||
| RA File Number<br>039404000527 AM21 | |||||
| Licence No and<br>Date<br>0310839017/20/10/2020 | |||||
| Norms Committee Decision: | |||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||||
| or as applied by the firm, whichever is less: | |||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | ||
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
19
UDIN00236046AM23
| Case No. | 34 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | INNOVARE LABS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | 018205001770AM21 |
| RA File Number | 262404000018 AM21 |
| Licence No and<br>Date | 2610012921/20/10/2020 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT<br>Portal. Hence, the Committee decided torejectthe case.<br> RA concerned may take further necessary action as per above decision of NC. |
| Case No. | Case No. | 35 / NC/3/MEET/Sep/202223/9 | 35 / NC/3/MEET/Sep/202223/9 | 35 / NC/3/MEET/Sep/202223/9 | 35 / NC/3/MEET/Sep/202223/9 | 35 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001766AM21 | |||||
| RA File Number | 039404000548 AM21 | |||||
| Licence No and<br>Date | 0310839000/20/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
20
UDIN00236046AM23
| Case No.<br>36 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>018205001778AM21 | ||||
| RA File Number<br>039404000412 AM21 | ||||
| Licence No and<br>Date<br>0310839084/23/10/2020 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 37 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | 018205001779AM21 |
| RA File Number | 039404000411 AM21 |
| Licence No and<br>Date | 0310839085/23/10/2020 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative | |
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
21
UDIN00236046AM23
or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg |
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 38 / NC/3/MEET/Sep/202223/9 | 38 / NC/3/MEET/Sep/202223/9 | 38 / NC/3/MEET/Sep/202223/9 | 38 / NC/3/MEET/Sep/202223/9 | 38 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001788AM21 | |||||
| RA File Number | 039404000410 AM21 | |||||
| Licence No and<br>Date | 0310839173/28/10/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP<br>Vol. I as per details given below or as applied by the firm, whichever is less:<br>Export Product<br>Qty<br>Sl. No. Import Item Name.<br>Qty.<br>1<br>2,4 Dichloro-5-Fluoro Acetophenone(DCFA)<br>0.877 kg<br>2<br>Dimethyl Carbonate<br>0.789 kg<br>3<br>Dimethyl Formamide<br>0.385 kg<br>4<br>Mono Ethyl Amine 70<br>0.439 kg<br>5<br>Piperazine Anhydrous<br>0.520 kg<br>Norfloxacin<br>1 kg | ||||||
| Export Product<br>Norfloxacin | Qty | Sl. No. | Import Item Name. | Qty. | ||
| 1 kg | 1 | 2,4 Dichloro-5-Fluoro Acetophenone(DCFA) | 0.877 kg | |||
| 2 | Dimethyl Carbonate | 0.789 kg | ||||
| 3 | Dimethyl Formamide | 0.385 kg | ||||
| 4 | Mono Ethyl Amine 70 | 0.439 kg | ||||
| 5 | Piperazine Anhydrous | 0.520 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
22
UDIN00236046AM23
6 Methanol 0.150 kg
| 6<br>Methanol<br>0.150 kg | 6 | Methanol | Methanol | Methanol | Methanol | 0.150 kg | 0.150 kg | |||
|---|---|---|---|---|---|---|---|---|---|---|
| RA concerned may | take further necessary action as per above decision of NC. | |||||||||
| Case No. | 39 / NC/3/MEET/Sep/202223/9 | |||||||||
| Case Status | Case Approved | |||||||||
| Party Name | AARTI DRUGS LIMITED | |||||||||
| Meeting Number | ||||||||||
| <br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||
| HQ File Number | 018205001789AM21 | |||||||||
| RA File Number | 039404000346 AM21 | |||||||||
| Licence No and<br>Date | 0310839184/28/10/2020 | |||||||||
| Norms Committee Decision: | ||||||||||
| The Committee co<br>d f h fi | nsidered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>i didd if dh d P 407 f HBP Vl I dil i bl | |||||||||
| <br>o | ata rom oter r<br>r as applied by th | s, t was ece to raty a<br>firm whichever is less: | c norms uner ara . o o. as per etas gven eow | |||||||
| , | ||||||||||
| Exort roduct | Qt | Sl No | Imort items | Qt | ||||||
| p p | y. | . . | p | y. | ||||||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||||||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||||||
| RA concerned may | take further necessary action a | s per above decision of NC. | ||||||||
| Case No. | 40 / NC/3/MEET/Sep/202223/9 | |||||||||
| Case Status | Case Approved | |||||||||
| Party Name | OPTIMUS DRUGS PRIVATE LIMITED | |||||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||
| HQ File Number | 018205001805AM21 | |||||||||
| RA File Number | 092404000389 AM21 | |||||||||
| Licence No and<br>Date | 0910069418/29/10/2020 | |||||||||
| Norms Committee Decision: |
| Case No. | 40 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | OPTIMUS DRUGS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | 018205001805AM21 |
| RA File Number | 092404000389 AM21 |
| Licence No and<br>Date | 0910069418/29/10/2020 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
23
UDIN00236046AM23
The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. | |
|---|---|---|---|---|---|
| (1R,2R)-2-amino-6-(4-nitrophenyl)-1- | 1 kg | 1 | 4-Pentyn-1-ol | 1.22 kg | |
| phenylhex-5-yn-1-ol hydrochloride | |||||
| 2 | Iodobenzene diacerate | 4.78 kg | |||
| 3 | Di-tert-butyl dicarbonate | (Boc anhydride) | 3.16 kg | ||
| 4 | KRED-208,<br>RVT-901 | LYOPHILIZED | <br>0.030 kg | ||
| ENZYME POWDER | |||||
| 5 | Beta-Nicotinamide adenine dinucleotide | <br>0.008 kg | |||
| phosphate Sodium salt (beta-NADP-Na) | |||||
| 6 | P-Iodonitro benzene | 0.904 kg |
| Case No. | Case No. | 41 / NC/3/MEET/Sep/202223/9 | 41 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|---|---|---|
| Case Status | Case Approved | ||||||
| Party Name | OPTIMUS DRUGS PRIVATE LIMITED | ||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||
| HQ File Number | 018205001804AM21 | ||||||
| RA File Number | 092404000388 AM21 | ||||||
| Licence No and<br>Date | 0910069417/29/10/2020 | ||||||
| Norms Committee Decision: | |||||||
| The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP | |||||||
| Vol. I as per details given below or as applied by the firm, whichever is less: | |||||||
| Export product | Qty. | Sl. No. | Import items | Qty. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
24
UDIN00236046AM23
| 1<br>4-Pentyn-1-ol<br>1.22 kg<br>2<br>Iodobenzene diacerate<br>4.78 kg<br>3<br>Di-tert-butyl dicarbonate (Boc anhydride)<br>3.16 kg<br>4<br>KRED-208,<br>RVT-901<br>LYOPHILIZED<br>ENZYME POWDER<br>0.030 kg<br>5<br>Beta-Nicotinamide adenine dinucleotide<br>phosphate Sodium salt (beta-NADP-Na)<br>0.008 kg<br>(1R,2R)-2-amino-6-(4-nitrophenyl)-1-<br>phenylhex-5-yn-1-ol hydrochloride<br>1 kg<br>6<br>P-Iodonitro benzene<br>0.904 kg<br>RA concerned may take further necessary action as per above decision of NC. | (1R,2R)-2-amino-6-(4-nitrophenyl)-1-<br>phenylhex-5-yn-1-ol hydrochloride | 1 kg | 1 | 4-Pentyn-1-ol | 1.22 kg |
|---|---|---|---|---|---|
| 2 | Iodobenzene diacerate | 4.78 kg | |||
| 3 | Di-tert-butyl dicarbonate (Boc anhydride) | 3.16 kg | |||
| 4 | KRED-208,<br>RVT-901<br>LYOPHILIZED<br>ENZYME POWDER | <br>0.030 kg | |||
| 5 | Beta-Nicotinamide adenine dinucleotide<br>phosphate Sodium salt (beta-NADP-Na) | <br>0.008 kg | |||
| 6 | P-Iodonitro benzene | 0.904 kg |
| Case No. | Case No. | 42 / NC/3/MEET/Sep/202223/9 | 42 / NC/3/MEET/Sep/202223/9 | 42 / NC/3/MEET/Sep/202223/9 | 42 / NC/3/MEET/Sep/202223/9 | 42 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | 018205001818AM21 | |||||
| RA File Number | 039404001085 AM20 | |||||
| Licence No and<br>Date | 0310839307/04/11/2020 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP<br>Vol. I as per details given below or as applied by the firm, whichever is less:<br>Export Product<br>Qty<br>Sl. No. Import Item Name.<br>Qty.<br>1<br>2,4 Dichloro-5-Fluoro Acetophenone(DCFA)<br>0.877 kg<br>2<br>Dimethyl Carbonate<br>0.789 kg<br>3<br>Dimethyl Formamide<br>0.385 kg<br>Norfloxacin<br>1 kg | ||||||
| Export Product<br>Norfloxacin | Qty | Sl. No. | Import Item Name. | Qty. | ||
| 1 kg | 1 | 2,4 Dichloro-5-Fluoro Acetophenone(DCFA) | 0.877 kg | |||
| 2 | Dimethyl Carbonate | 0.789 kg | ||||
| 3 | Dimethyl Formamide | 0.385 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
25
UDIN00236046AM23
| 4 | Mono Ethyl Amine 70 | 0.439 kg | |
|---|---|---|---|
| 5 | Piperazine Anhydrous | 0.520 kg | |
| 6 | Methanol | 0.150 kg |
| 4 | Mono Ethyl Amine 70 | 0.439 kg | ||||||||||
| 5 | Piperazine Anhydrous | 0.520 kg | ||||||||||
| 6<br>Methanol<br>0.150 kg<br> <br>RA concerned may take further necessary action as per above decision of NC. | 6 | Methanol | 0.150 kg | |||||||||
| Case No. | 43 / NC/3/MEET/Sep/202223/9 | |||||||||||
| Case Status | Case Approved | |||||||||||
| Party Name | AARTI DRUGS LIMITED | |||||||||||
| Meeting Number<br>d D | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||||
| an ate | ||||||||||||
| HQ File Number | 018205001826AM21 | |||||||||||
| RA File Number | 039404000596 AM21 | |||||||||||
| Licence No and<br>Date | 0310839361/05/11/2020 | |||||||||||
| Norms Committee | Decision: | |||||||||||
| The Committee co | nsidered the case as per agenda and on the basis GST data furnished by the firm and comparative | |||||||||||
| data from other fir | ms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||||||||||
| o | r as applied by the | firm, whichever is less: | ||||||||||
| R | ||||||||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||||||||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP Cifli | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Flbl Alt | 1.240 kg | ||||||||
| (prooxacn) | uoroenzoy) cryae | |||||||||||
| 2 | Pii Ahd | 0390 k | ||||||||||
| perazne nyrous | . g | |||||||||||
| A concerned may take further nece | ssary act | b dii f C | ||||||||||
| on a | s pe | r aove ecson o N. | ||||||||||
| C | ase No. | 44 / NC/3/MEET/ | Sep/2022 | 23/9 | ||||||||
| C | ase Status | Case Approved | ||||||||||
| P | arty Name | AARTI DRUGS | LIMITED | |||||||||
| M<br>a | eeting Number<br>nd Date | NC/ 3/ MEET/ Se | p/ 20222 | 3/ 9 and | 07/10/2022 |
| Case No. | 44 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
26
UDIN00236046AM23
| HQ File Number<br>018205001827AM21 | ||||
|---|---|---|---|---|
| RA File Number<br>039404000597 AM21 | ||||
| Licence No and<br>Date<br>0310839362/05/11/2020 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No.<br>45 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>SYNNAT PHARMA PRIVATE LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>HQRNORM REVIW00000390AM23 | ||||
| RA File Number<br>022404000099 AM21 | ||||
| Licence No and<br>Date<br>0210210204/09/11/2020 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the request of firm for review of adhoc norms and taking cue from earlier decision for | ||||
| same export product / import item in Meeting No.NC/3/MEET/Aug/202223/6 dated 09.09.2022against advance | ||||
| authorization No.0210208260 dated 07.03.2018, it was decided to ratify adhoc norms under Para | 4.07 of HBP Vol. | |||
| I as per details given below or as applied by the firm, whichever is | less: | |||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. | ||
| Noscapine BP USP Ph.Eur JP CP / Noscapine<br>1 kg<br>1 | Noscapine Crude Content 95% | 1.158 kg | ||
| Hydrochloride BP Ph.Eur |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
27
UDIN00236046AM23
| Case No.<br>46 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>018205001844AM21 | ||||
| RA File Number<br>039404000423 AM21 | ||||
| Licence No and<br>Date<br>0310839485/11/11/2020 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 47 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | APEX DRUG HOUSE |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00001832AM23 |
| RA File Number | 03AA04013443 AM21 |
| Licence No and<br>Date | 0311000381/23/12/2020 |
| Norms Committee Decision: | |
| The Committee considered the request of firm for review of adhoc norms andit was observed that the firm has not | |
| given any technical details in support of its request. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
28
UDIN00236046AM23
In view of above, the Committee decided to reject the case.
| Case No. | Case No. | 48 / NC/3/MEET/Sep/202223/9 | 48 / NC/3/MEET/Sep/202223/9 | 48 / NC/3/MEET/Sep/202223/9 | 48 / NC/3/MEET/Sep/202223/9 | 48 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00063660AM21 | |||||
| RA File Number | 03AA04018890 AM21 | |||||
| Licence No and<br>Date | 0311001030/16/01/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 49 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00067209AM21 |
| RA File Number | 03AA04019643 AM21 |
| Licence No and<br>Date | 0311001122/21/01/2021 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
29
UDIN00236046AM23
The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg |
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 50 / NC/3/MEET/Sep/202223/9 | 50 / NC/3/MEET/Sep/202223/9 | 50 / NC/3/MEET/Sep/202223/9 | 50 / NC/3/MEET/Sep/202223/9 | 50 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00067214AM21 | |||||
| RA File Number | 03AA04019645 AM21 | |||||
| Licence No and<br>Date | 0311001129/21/01/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
30
UDIN00236046AM23
| Case No.<br>51 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>HQRNORM APPLY 00067215AM21 | ||||
| RA File Number<br>03AA04019655 AM21 | ||||
| Licence No and<br>Date<br>0311001134/21/01/2021 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 52 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00067217AM21 |
| RA File Number | 03AA04019654 AM21 |
| Licence No and<br>Date | 0311001138/21/01/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative | |
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |
| or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
31
UDIN00236046AM23
| Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|---|
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | |
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 53 / NC/3/MEET/Sep/202223/9 | 53 / NC/3/MEET/Sep/202223/9 | 53 / NC/3/MEET/Sep/202223/9 | 53 / NC/3/MEET/Sep/202223/9 | 53 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00068617AM21 | |||||
| RA File Number | 03AA04020063 AM21 | |||||
| Licence No and<br>Date | 0311001190/22/01/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 54 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
32
UDIN00236046AM23
| HQ File Number<br>HQRNORM APPLY 00068219AM21 | HQ File Number<br>HQRNORM APPLY 00068219AM21 | |||
|---|---|---|---|---|
| RA File Number<br>03AA04020020 AM21 | ||||
| Licence No and<br>Date<br>0311001191/22/01/2021 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No.<br>55 / NC/3/MEET/Sep/202223/9 | Case No.<br>55 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|---|
| Case Status<br>Case Approved | |||||
| Party Name<br>AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number<br>HQRNORM APPLY 00069628AM21 | |||||
| RA File Number<br>03AA04020216 AM21 | |||||
| Licence No and<br>Date<br>0311001225/25/01/2021 | |||||
| Norms Committee Decision: | |||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||||
| or as applied by the firm, whichever is less: | |||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | ||
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
33
UDIN00236046AM23
2 Piperazine Anhydrous 0.390 kg
| Case No. | 56 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | ASHISH LIFE SCIENCE PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00001578AM23 |
| RA File Number | 03AA04021189 AM21 |
| Licence No and<br>Date | 0311001372/01/02/2021 |
| Norms Committee Decision: | |
| The Committee considered the request of firm for fixation of adhoc norms and it was decided to call for following | |
| information/documents from the firm: | |
| Master Batch Formula given was found incomplete. Content of import item in Master Batch Formula was not<br>i. | |
| shown. |
| Case No.<br>57 / NC/3/MEET/Sep/202223/9 | Case No.<br>57 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|---|
| Case Status<br>Case Approved | |||||
| Party Name<br>AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number<br>HQRNORM APPLY 00075441AM21 | |||||
| RA File Number<br>03AA04021687 AM21 | |||||
| Licence No and<br>Date<br>0311001421/02/02/2021 | |||||
| Norms Committee Decision: | |||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||||
| or as applied by the firm, whichever is less: | |||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | ||
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
34
UDIN00236046AM23
2 Piperazine Anhydrous 0.390 kg
| Case No. | 58 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | BALAJI SPECIALITY CHEMICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000228AM23 |
| RA File Number | 31AA04006051 AM21 |
| Licence No and<br>Date | 3111000148/09/02/2021 |
| Norms Committee Decision:<br>The Committee considered the request of firm for review of adhoc norms and it was observed that the firm still has not<br>furnished its reply on DGFT Portal. Hence, the Committee decided torejectthe case.<br> RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 59 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | INDOCO REMEDIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000695AM23 |
| RA File Number | 03AA04023340 AM21 |
| Licence No and<br>Date | 0311001698/16/02/2021 |
| Norms Committee Decision:<br>The Committee considered the request of firm for fixation of adhoc norms andit was observed that the description of<br>import item No. 1 – Brimonidine does not match with the DML furnished by the firm.<br>In view of above, the Committee decided torejectthe case.<br> RA concerned may take further necessary action as per above decision of |
| Case No. | 60 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
35
UDIN00236046AM23
| Meeting Number<br>and Date | Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
|---|---|---|---|---|---|---|
| HQ File Number | HQRNORM APPLY 00093160AM21 | |||||
| RA File Number | 03AA04024760 AM21 | |||||
| Licence No and<br>Date | 0311001926/26/02/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | Case No. | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00094934AM21 | |||||
| RA File Number | 03AA04026242 AM21 | |||||
| Licence No and<br>Date | 0311002125/02/03/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>Ciprofloxacin<br>Hydrochloride<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>1 kg<br>1<br>1.240 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
| Case No. | Case No. | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 | 61 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00094934AM21 | |||||
| RA File Number | 03AA04026242 AM21 | |||||
| Licence No and<br>Date | 0311002125/02/03/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>Ciprofloxacin<br>Hydrochloride<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>1 kg<br>1<br>1.240 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
36
UDIN00236046AM23
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
|---|---|---|---|---|
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 62 / NC/3/MEET/Sep/202223/9 | 62 / NC/3/MEET/Sep/202223/9 | 62 / NC/3/MEET/Sep/202223/9 | 62 / NC/3/MEET/Sep/202223/9 | 62 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00096069AM21 | |||||
| RA File Number | 03AA04027466 AM21 | |||||
| Licence No and<br>Date | 0311002195/03/03/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 63 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00097305AM21 |
| RA File Number | 039404000673 AM21 |
| Licence No and | 0311001441/04/03/2021 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
37
UDIN00236046AM23
Date
Norms Committee Decision:
The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. | |
|---|---|---|---|---|---|
| Ciprofloxacin | Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | 64 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | STERILE INDIA PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000419AM23 |
| RA File Number | 05AA04037727 AM21 |
| Licence No and<br>Date | 0511001580/08/03/2021 |
| Norms Committee Decision: | |
| The Committee considered the request of firm for fixation of adhoc norms and it was decided to call for following | |
| information/documents from the firm: | |
| Approved composition of export product as per DML.<br>i. | |
| Master Batch Formula.<br>ii. | |
| Wastage claimed.<br>iii. |
| Case No. | 65 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | BALAJI SPECIALITY CHEMICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00000226AM23 |
| RA File Number | 31AA04006435 AM21 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
38
UDIN00236046AM23
Licence No and 3111000179/08/03/2021 Date Norms Committee Decision: The Committee considered the request of firm for review of adhoc norms and it was observed that the firm still has not furnished its reply on DGFT Portal. Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.
| Case No.<br>66 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>HQRNORM APPLY 00098942AM21 | ||||
| RA File Number<br>03AA04022238 AM21 | ||||
| Licence No and<br>Date<br>0311001500/08/03/2021 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 67 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00100470AM21 |
| RA File Number | 03AA04028406 AM21 |
| Licence No and | 0311002391/10/03/2021 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
39
UDIN00236046AM23
Date
Norms Committee Decision:
The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. | |
|---|---|---|---|---|---|
| Ciprofloxacin | Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No.<br>68 / NC/3/MEET/Sep/202223/9 | Case No.<br>68 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|---|
| Case Status<br>Case Approved | |||||
| Party Name<br>AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number<br>HQRNORM APPLY 00100472AM21 | |||||
| RA File Number<br>03AA04028410 AM21 | |||||
| Licence No and<br>Date<br>0311002393/10/03/2021 | |||||
| Norms Committee Decision: | |||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||||
| or as applied by the firm, whichever is less: | |||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | ||
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg | |||
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
40
UDIN00236046AM23
| Case No. | Case No. | 69 / NC/3/MEET/Sep/202223/9 | 69 / NC/3/MEET/Sep/202223/9 | 69 / NC/3/MEET/Sep/202223/9 | 69 / NC/3/MEET/Sep/202223/9 | 69 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00108415AM21 | |||||
| RA File Number | 03AA04028192 AM21 | |||||
| Licence No and<br>Date | 0311002303/22/03/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 70 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00108766AM21 |
| RA File Number | 039404000652 AM21 |
| Licence No and<br>Date | 0311002733/22/03/2021 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
41
UDIN00236046AM23
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg |
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 71 / NC/3/MEET/Sep/202223/9 | 71 / NC/3/MEET/Sep/202223/9 | 71 / NC/3/MEET/Sep/202223/9 | 71 / NC/3/MEET/Sep/202223/9 | 71 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | GRANULES INDIA LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00117194AM21 | |||||
| RA File Number | 09AA04006983 AM21 | |||||
| Licence No and<br>Date | 0911000644/31/03/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP<br>Vol. I as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Azathioprine<br>150.00 kg<br>2<br>Cellulose Microcristalline<br>150.00 kg<br>3<br>Mannitol<br>150.00 kg<br>4<br>Corn Starch<br>42.00 kg<br>5<br>Croscarmellose Sodium<br>16.50 kg<br>AZATHIOPRINE 25mg<br>6000000<br>Number | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| AZATHIOPRINE 25mg | 6000000<br>Number | 1 | Azathioprine | 150.00 kg | ||
| 2 | Cellulose Microcristalline | 150.00 kg | ||||
| 3 | Mannitol | 150.00 kg | ||||
| 4 | Corn Starch | 42.00 kg | ||||
| 5 | Croscarmellose Sodium | 16.50 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
42
UDIN00236046AM23
| 6 | Povidone K | 24.00 kg | |
|---|---|---|---|
| 7 | Sodium Stearyl Fumarate | 7.50 kg | |
| 8 | Hypromellose | 6.90 kg | |
| 9 | Macrogol | 1.20 kg |
| 6 | Povidone K | 24.00 kg | ||||||||||
| 7 | Sodium Stearyl Fumarate | 7.50 kg | ||||||||||
| 8 | Hypromellose | 6.90 kg | ||||||||||
| 9 | Macrogol | 1.20 kg | ||||||||||
| R | A concerned may take furthe | r necessary ac | tion as per | above decision of NC. | ||||||||
| C | ase No. | 72 / NC/3/ | MEET/Sep/202 | 223/9 | ||||||||
| C | ase Status | Case Appro | ved | |||||||||
| P | arty Name | GRANULE | S INDIA | LIM | ITED | |||||||
| M<br>a | eeting Number<br> | NC/ 3/ ME | ET/ Sep/ 2 | 0222 | ||||||||
| 3/ 9 a | nd 0 | 7/1 | /2022 | |||||||||
| nd Date | ||||||||||||
| H | Q File Number | HQRNOR | M APPLY | 001 | 17574 | AM2 | 1 | |||||
| R | A File Number | 09AA0400 | 5560 AM2 | 1 | ||||||||
| L<br>D | icence No and<br>ate | 091100047 | 6/31/03/20 | 21 | ||||||||
| N<br>T<br>V | orms Committee Decision: | |||||||||||
| he Committee considered the case as per agenda<br>ol. I as per details given below or as applied by | and it was decided to ratify adhoc norms under Para 4.07 of HBP<br>the firm, whichever is less: | |||||||||||
| xort rouct | t | o | mort tems | t | ||||||||
| p p | y. | . . | p | y. | ||||||||
| HYDROXYURE | A CAPSULES | <br>1350000 | 1 | Hydroxyurea USP | 675.00 kg | |||||||
| 500 mg | ||||||||||||
| Nb | ||||||||||||
| umer | 2 | Cllidl Sili Diid NF | 203 k | |||||||||
| ooa con oxe | . | |||||||||||
| 3 | Magnesium Stearate | 0.68 kg | ||||||||||
| 4 | Capsule size1 | 1363500 | ||||||||||
| Number | ||||||||||||
| RA concerned may | take further necessary action a | s per above decision of NC. | ||||||||||
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
43
UDIN00236046AM23
| Case No.<br>73 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>HQRNORM APPLY 00003027AM22 | ||||
| RA File Number<br>03AA04031763 AM21 | ||||
| Licence No and<br>Date<br>0311002768/05/04/2021 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 74 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00003031AM22 |
| RA File Number | 039404000229 AM21 |
| Licence No and<br>Date | 0311002737/05/04/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative | |
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |
| or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
44
UDIN00236046AM23
| Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|---|
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | |
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | 75 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | NASENSE LABS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00019535AM22 |
| RA File Number | 09AA04000085 AM22 |
| Licence No and<br>Date | 0911000683/15/04/2021 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT<br>Portal. Hence, the Committee decided torejectthe case.<br> RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 76 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | SUDEEP PHARMA PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00020260AM22 |
| RA File Number | 34AA04000021 AM22 |
| Licence No and<br>Date | 3411000455/16/04/2021 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to call for following information/documents from the<br>firm:<br>Specific name of Vegetable Oil to be imported. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
45
UDIN00236046AM23
| Case No. | 77 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | GARUDA CHEMICALS |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00024406AM22 |
| RA File Number | 03AA04031910 AM21 |
| Licence No and<br>Date | 0311003270/22/04/2021 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT<br>Portal. Hence, the Committee decided torejectthe case.<br> RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 78 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | BHAGWATI INDUSTRIES |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00029214AM22 |
| RA File Number | 08AA04001833 AM22 |
| Licence No and<br>Date | 0811001364/29/04/2021 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT<br>Portal. Hence, the Committee decided torejectthe case.<br> RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 79 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00032713AM22 |
| RA File Number | 05AA04009888 AM22 |
| Licence No and<br>Date | 0511002414/04/05/2021 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
46
UDIN00236046AM23
The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT Portal. Hence, the Committee decided to reject the case.
| Case No. | 80 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | SUDEEP PHARMA PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00033649AM22 |
| RA File Number | 34AA04000874 AM22 |
| Licence No and<br>Date | 3411000530/05/05/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 81 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | PORUS LABORATORIES PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00036920AM22 |
| RA File Number | 09AA04002104 AM22 |
| Licence No and<br>Date | 0911000798/10/05/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 82 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SAGA LIFESCIENCES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
47
UDIN00236046AM23
| HQ File Number<br>HQRNORM REVIW00001672AM23 | |||
|---|---|---|---|
| RA File Number<br>08AA04003764 AM22 | |||
| Licence No and<br>Date<br>0811001516/18/05/2021 | |||
| Norms Committee Decision: | |||
| The Committee considered the request of firm for review of adhoc norms and taking cue from earlier decision for | |||
| same export product / import item in Meeting No.NC/3/MEET/Sep/202122/8 dated 24.09.2021against advance | |||
| authorization No.0810147725 dated 11.05.2020, it was decided to ratify adhoc norms under Para 4.07 | of HBP Vol. I | ||
| as per details given below or as applied by the firm, whichever is less: | |||
| Export Product<br>Qty.<br>Sl. No. Import items | Qty. | ||
| Diosmin and Hesperidin Tablets 500 mg<br>1 Number<br>1<br>DIOSMIN + HESPERIDIN 9:1 | <br>564.29 mg | ||
| (1091 KGS)<br>Tablet<br>(Assay NMT 93% and Water | |||
| content NLT 2.9%) | |||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 83 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | NASENSE LABS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00046900AM22 |
| RA File Number | 09AA04002898 AM22 |
| Licence No and<br>Date | 0911000881/20/05/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 84 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00047353AM22 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
48
UDIN00236046AM23
| RA File Number<br>03AA04031724 AM21 | ||||
|---|---|---|---|---|
| Licence No and<br>Date<br>0311002771/21/05/2021 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 85 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | TADIMETY AROMATICS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00047898AM22 |
| RA File Number | 07AA04004515 AM22 |
| Licence No and<br>Date | 0711001152/21/05/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 86 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | SAKAR HEALTHCARE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00099634AM22 |
| RA File Number | 08AA04004104 AM22 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
49
UDIN00236046AM23
Licence No and 0811001574/25/05/2021 Date Norms Committee Decision:
The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT Portal. Hence, the Committee decided to reject the case.
| Case No. | Case No. | 87 / NC/3/MEET/Sep/202223/9 | 87 / NC/3/MEET/Sep/202223/9 | ||
|---|---|---|---|---|---|
| Case Status | Case Approved | ||||
| Party Name | DIAMINES AND CHEMICALS LIMITED | ||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number | HQRNORM APPLY | 00101253AM22 | |||
| RA File Number | 34AA04001451 AM22 | ||||
| Licence No and<br>Date | 3411000643/27/05/2021 | ||||
| Norms Committee Decision: | |||||
| The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP | |||||
| Vol. I as per details given below or as applied by the firm, whichever is less: | |||||
| Export Product | Qty<br>Sl. | Import Item Name. | Qty. | ||
| No. | |||||
| PIPERAZINE | 1 kg<br>1 | PIPERAZINE CRUDE OR PIPERAZINE MIXTURE | 2.047 kg | ||
| ANHYDROUS | |||||
| (Percentage purity NMT 48.1%) | |||||
| <br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 88 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | ATUL LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00102193AM22 |
| RA File Number | 08AA04005014 AM22 |
| Licence No and<br>Date | 0811001601/28/05/2021 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
50
UDIN00236046AM23
Norms Committee Decision:
The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export Product | Qty | Sl.<br>No. | Import Item Name. | Qty. |
|---|---|---|---|---|
| Formulated Aromatic<br>Amine<br>1<br>(Brown<br>liquid, curing agent for<br>epoxy resin) | <br> <br> <br>1 kg | 1 | Aniline / Aniline Oil | 0.683 kg |
| 2 | Methanol | 0.158 kg | ||
| 3 | Di Ethyl Toluene Diamine / Ethacure 100 / Lonzacure<br>DETDA 80 / DETDA 80 / DETDA | <br>0.202 kg | ||
| 4 | Iso Phoron Diamine / Vestamine IPD / Baxxodur EC 201 /<br>Wanamine IPDA | <br>0.101 kg |
| Case No. | 89 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | ATUL LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00104366AM22 |
| RA File Number | 08AA04004876 AM22 |
| Licence No and<br>Date | 0811001618/01/06/2021 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to call for following information/documents from the<br>firm:<br>The firm has given chemical reactions, starting from Formaldehyde as import item is Methanol. Therefore, the firm<br>is requested to give complete chemistry from Methane. |
| Case No. | 90 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | ENCUBE ETHICALS PRIVATE LIMITED |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
51
UDIN00236046AM23
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
|---|---|
| HQ File Number | HQRNORM APPLY 00105763AM22 |
| RA File Number | 03AA04017165 AM22 |
| Licence No and<br>Date | 0311004253/02/06/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 91 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | ENCUBE ETHICALS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00107373AM22 |
| RA File Number | 03AA04018281 AM22 |
| Licence No and<br>Date | 0311004321/04/06/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 92 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | GLENMARK PHARMACEUTICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00109350AM22 |
| RA File Number | 03AA04023320 AM22 |
| Licence No and<br>Date | 0311004415/08/06/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
52
UDIN00236046AM23
| Case No. | 93 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | SV PLASTOCHEM PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00111363AM22 |
| RA File Number | 31AA04004163 AM22 |
| Licence No and<br>Date | 3111000397/10/06/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 94 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | ENCUBE ETHICALS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00113434AM22 |
| RA File Number | 03AA04015087 AM22 |
| Licence No and<br>Date | 0311004561/12/06/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT | |
| Portal. Hence, the Committee decided torejectthe case. | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 95 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Rejected |
| Party Name | SV PLASTOCHEM PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00113697AM22 |
| RA File Number | 31AA04007148 AM21 |
| Licence No and<br>Date | 3111000400/14/06/2021 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
53
UDIN00236046AM23
Norms Committee Decision:
The Committee considered the case as per agenda and it was observed that the firm still has not furnished its reply on DGFT Portal. Hence, the Committee decided to reject the case.
| Case No.<br>96 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>HQRNORM APPLY 00184798AM22 | ||||
| RA File Number<br>03AA04091486 AM22 | ||||
| Licence No and<br>Date<br>0311007000/15/09/2021 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| Ciprofloxacin<br>Hydrochloride<br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 97 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SENTISS PHARMA PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM REVIW00001812AM23 |
| RA File Number | 05AA040108674 AM22 |
| Licence No and<br>Date | 0511006625/03/12/2021 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
54
UDIN00236046AM23
The Committee considered the request of firm for review of adhoc norms and it was decided to revise adhoc norms as under:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Mydrimax Eye Drops 5 ml (Mydrimax Eye | <br>1 Number | 1 | Tropicamide | 40.8 mg / |
| Drops 5 ml) (Each ml Containing 8 mg | ||||
| Tropicamide) | 5 ml vial |
| Case No.<br>98 / NC/3/MEET/Sep/202223/9 |
|---|
| Case Status<br>Case Deferred |
| Party Name<br>SHIVAM ADDITIVES PRIVATE LIMITED |
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number<br>HQRNORM REVIW00001552AM23 |
| RA File Number<br>13AX04000009 AM22 |
| Licence No and<br>Date<br>1311000821/15/12/2021 |
| Norms Committee Decision: |
| The Committee considered the request of firm for review of adhoc norms and it was decided to call for following |
| information/documents from the firm: |
| COA of import item indicating exact purity of import item alongwith Bill of Entry indicating exact<br>i. |
| percentage of purity. |
- i. COA of import item indicating exact purity of import item alongwith Bill of Entry indicating exact percentage of purity.
| Case No. | 99 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00287541AM22 |
| RA File Number | 03AA040131415 AM22 |
| Licence No and<br>Date | 0311009528/16/12/2021 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
55
UDIN00236046AM23
data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg |
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 100 / NC/3/MEET/Sep/202223/9 | 100 / NC/3/MEET/Sep/202223/9 | 100 / NC/3/MEET/Sep/202223/9 | 100 / NC/3/MEET/Sep/202223/9 | 100 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00292375AM22 | |||||
| RA File Number | 03AA040131528 AM22 | |||||
| Licence No and<br>Date | 0311009652/21/12/2021 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
56
UDIN00236046AM23
| Case No.<br>101 / NC/3/MEET/Sep/202223/9 | ||||
|---|---|---|---|---|
| Case Status<br>Case Approved | ||||
| Party Name<br>AARTI DRUGS LIMITED | ||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number<br>HQRNORM APPLY 00300612AM22 | ||||
| RA File Number<br>03AX04000458 AM22 | ||||
| Licence No and<br>Date<br>0311009880/29/12/2021 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||
| data from other firms, it was decided to ratify adhoc norms | under Para 4.07 of HBP Vol. I as per details given below | |||
| or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. | ||
| 1<br>Ciprofloxacin<br>Hydrochloride<br>1 kg | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | ||
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | |||
| 2 | Piperazine Anhydrous | 0.390 kg | ||
| RA concerned may take further necessary action as per above decision of NC. |
| Case No.<br>102 / NC/3/MEET/Sep/202223/9 | Case No.<br>102 / NC/3/MEET/Sep/202223/9 | Case No.<br>102 / NC/3/MEET/Sep/202223/9 | Case No.<br>102 / NC/3/MEET/Sep/202223/9 | |||
|---|---|---|---|---|---|---|
| Case Status<br>Case Approved | ||||||
| Party Name<br>AARTI DRUGS LIMITED | ||||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||
| HQ File Number<br>HQRNORM APPLY 00300738AM22 | ||||||
| RA File Number<br>03AX04000454 AM22 | ||||||
| Licence No and<br>Date<br>0311009888/29/12/2021 | ||||||
| Norms Committee Decision: | ||||||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | |||||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||||
| or as applied by the firm, whichever is less: | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
57
UDIN00236046AM23
| Ciprofloxacin | Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
|---|---|---|---|---|---|
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No.<br>103 / NC/3/MEET/Sep/202223/9 | |||
|---|---|---|---|
| Case Status<br>Case Approved | |||
| Party Name<br>AARTI DRUGS LIMITED | |||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||
| HQ File Number<br>HQRNORM APPLY 00301808AM22 | |||
| RA File Number<br>03AX04000439 AM22 | |||
| Licence No and<br>Date<br>0311009908/30/12/2021 | |||
| Norms Committee Decision: | |||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||
| or as applied by the firm, whichever is less: | |||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. | |
| 1<br>Ciprofloxacin<br>Hydrochloride<br>1 kg | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||
| 2 | Piperazine Anhydrous | 0.390 kg | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 104 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00305699AM22 |
| RA File Number | 03AA040128756 AM22 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
58
UDIN00236046AM23
| Licence No and<br>Date | Licence No and<br>Date | 0311009997/03/01/2022 | 0311009997/03/01/2022 | 0311009997/03/01/2022 | 0311009997/03/01/2022 | 0311009997/03/01/2022 |
|---|---|---|---|---|---|---|
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | Case No. | 105 / NC/3/MEET/Sep/202223/9 | 105 / NC/3/MEET/Sep/202223/9 | 105 / NC/3/MEET/Sep/202223/9 | 105 / NC/3/MEET/Sep/202223/9 | 105 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00320476AM22 | |||||
| RA File Number | 03AX04000684 AM22 | |||||
| Licence No and<br>Date | 0311010562/17/01/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
59
UDIN00236046AM23
| Case No.<br>106 / NC/3/MEET/Sep/202223/9 | |||
|---|---|---|---|
| Case Status<br>Case Approved | |||
| Party Name<br>AARTI DRUGS LIMITED | |||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||
| HQ File Number<br>HQRNORM APPLY 00320474AM22 | |||
| RA File Number<br>03AA040113369 AM22 | |||
| Licence No and<br>Date<br>0311010560/17/01/2022 | |||
| Norms Committee Decision: | |||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||
| or as applied by the firm, whichever is less: | |||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. | |
| 1<br>Ciprofloxacin<br>Hydrochloride<br>1 kg | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||
| 2 | Piperazine Anhydrous | 0.390 kg | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 107 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00322636AM22 |
| RA File Number | 03AA04044735 AM22 |
| Licence No and<br>Date | 0311010626/18/01/2022 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP | |
| Vol. I as per details given below or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
60
UDIN00236046AM23
| Export Product | Qty | Sl. No. | Import Item Name. | Qty. |
|---|---|---|---|---|
| Norfloxacin | 1 kg | 1 | 2,4 Dichloro-5-Fluoro Acetophenone(DCFA) | 0.877 kg |
| 2 | Dimethyl Carbonate | 0.789 kg | ||
| 3 | Dimethyl Formamide | 0.385 kg | ||
| 4 | Mono Ethyl Amine 70 | 0.439 kg | ||
| 5 | Piperazine Anhydrous | 0.520 kg | ||
| 6 | Methanol | 0.150 kg |
| Case No. | Case No. | 108 / NC/3/MEET/Sep/202223/9 | 108 / NC/3/MEET/Sep/202223/9 | 108 / NC/3/MEET/Sep/202223/9 | 108 / NC/3/MEET/Sep/202223/9 | 108 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00331312AM22 | |||||
| RA File Number | 03AX04000872 AM22 | |||||
| Licence No and<br>Date | 0311010876/25/01/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
61
UDIN00236046AM23
2 Piperazine Anhydrous 0.390 kg
| Case No. | Case No. | 109 / NC/3/MEET/Sep/202223/9 | 109 / NC/3/MEET/Sep/202223/9 | 109 / NC/3/MEET/Sep/202223/9 | 109 / NC/3/MEET/Sep/202223/9 | 109 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00356040AM22 | |||||
| RA File Number | 03AX04001181 AM22 | |||||
| Licence No and<br>Date | 0311011428/15/02/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 110 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | MEGHMANI NOVOTECH PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00357589AM22 |
| RA File Number | 08AX04000262 AM22 |
| Licence No and<br>Date | 0811004084/16/02/2022 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
62
UDIN00236046AM23
Deferred for comments of TE
| Deferred for comme | nts of TE | |||||||||
| Case No. | 111 / NC/3/MEET/Sep/202223/9 | |||||||||
| Case Status | Case Approved | |||||||||
| Party Name | YASHO INDUSTRIES LIMITED | |||||||||
| M<br>a | eeting Number<br>nd Date | NC/ 3/ MEET/ Sep/ 202223/ 9 a | nd 07/10/2022 | |||||||
| H | Q File Number | HQRNORM APPLY 00358825 | AM22 | |||||||
| R | ||||||||||
| A File Number | 03AX04001322 AM2 | 2 | ||||||||
| L<br>D | icence No and<br>ate | 0311011513/17/02/20 | 22 | |||||||
| N<br>T<br>i<br>0<br>g | orms Committee Decision:<br>he Committee considered the case as<br>mport item in Meeting No.NC/3/M<br>311005604 dated 25.07.2021, it was de<br>iven below or as applied by the firm, w | per agen<br>EET/Apr<br>cided to<br>hichever i | da and t<br>/202223 | aking cue from earlier decision for same ex<br>/1 dated 29042022aainst advance auth | port product /<br>orization No | |||||
| <br>ratify ad<br>s less: | **..**g<br>hoc norms under Para 4.07 of HBP Vol. I<br> | .<br>as per details | ||||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||||||
| DI-NONYLATE | D | 1 kg | 1 | DIPHENYLAMINE | 0.4134 kg | |||||
| DIPHENYLAM | INE (YALUB DND) | |||||||||
| 2 | NONENE | 0.4 kg | ||||||||
| 3 | ACTIVATED CLAY | 0.05 kg | ||||||||
| RA concerned may take further necessary action as per above decision of NC. | ||||||||||
| C N | 112 / NC/3/MEET/S/202223/9 | |||||||||
| ase o. | ep | |||||||||
| C Stt | C Ad | |||||||||
| ase aus | ase pprove | |||||||||
| P N | DANOPHARM CHEMICALS PRIVATE LIMITED | |||||||||
| arty ame | ||||||||||
| Mi Nb | ||||||||||
| eetng umer<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||
| HQ File Number | HQRNORM APPLY 00358236AM22 | |||||||||
| RA Fil Nb | 039404000737 AM20 | |||||||||
| e umer | ||||||||||
| Li N d | ||||||||||
| cence o an<br>Date | 0311011493/17/02/2022 | |||||||||
| Norms Committee | Decision: | |||||||||
| The Committee considered the case as per agenda and taking cue from earlier decision for same export product / | ||||||||||
| Case No. | 112 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | DANOPHARM CHEMICALS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00358236AM22 |
| RA File Number | 039404000737 AM20 |
| Licence No and<br>Date | 0311011493/17/02/2022 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and taking cue from earlier decision for same export product / |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
63
UDIN00236046AM23
import item in Meeting No. NC/3/MEET/Aug/202122/7 dated 13.08.2021 against advance authorization No. 0310831769 dated 24.09.2019 , it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Alpha-(2,4-dichlorophenyl)-<br>1H-imidazole-1-ethanol | 1 kg | 1 | 2,2,4 Trichloro Acetophenone | 1.45 kg |
| 2 | Imidazole | 0.53 kg | ||
| 3 | Sodium Carbonate | Not shown in the process | ||
| 4 | Sodium Borohydride | 0.10 kg | ||
| 5 | Dimethyl Sulphoxide (DMSO) | 0.42 kg | ||
| 6 | Toluene | 0.45 kg | ||
| 7 | Sodium Hydroxide (NaOH) | 0.10 kg | ||
| 8 | Activated Carbon | 0.050 kg |
| Case No. | 113 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | PI INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00358447AM22 |
| RA File Number | 13AX04000083 AM22 |
| Licence No and<br>Date | 1311001018/17/02/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP<br>Vol. I as per details given below or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
64
UDIN00236046AM23
| Export Product | Qty | Sl. | Import Item Name. | Qty. |
|---|---|---|---|---|
| No. | ||||
| PIA - 4 Chemical Name: 3- | 1 kg | 1 | 3-Chloro -2-Methyl aniline | 0.620 kg |
| (bromomethyl)-2-chloro-4- | ||||
| (methylsulfonyl)benzoic acid | 2 | Sodium Nitrite | 0.366 kg | |
| 3 | Sodium Methyl Mercaptide | 1.570 kg | ||
| 4 | Bromine | 0.634 kg |
| Case No. | Case No. | 114 / NC/3/MEET/Sep/202223/9 | 114 / NC/3/MEET/Sep/202223/9 | ||
|---|---|---|---|---|---|
| Case Status | Case Approved | ||||
| Party Name | DIAMINES AND CHEMICALS LIMITED | ||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||
| HQ File Number | HQRNORM APPLY | 00358616AM22 | |||
| RA File Number | 34AX04000258 AM22 | ||||
| Licence No and<br>Date | 3411001810/17/02/2022 | ||||
| Norms Committee Decision: | |||||
| The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP | |||||
| Vol. I as per details given below or as applied by the firm, whichever is less: | |||||
| Export Product | Qty<br>Sl. | Import Item Name. | Qty. | ||
| No. | |||||
| PIPERAZINE | 1 kg<br>1 | PIPERAZINE CRUDE OR PIPERAZINE MIXTURE | 2.047 kg | ||
| ANHYDROUS | |||||
| (Percentage purity NMT 48.1%) | |||||
| <br>RA concerned may take further necessary action as per above decision of NC. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
65
UDIN00236046AM23
| Case No. | 115 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | REYAANSH HEALTHCARE |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00359289AM22 |
| RA File Number | 03AX04001240 AM22 |
| Licence No and<br>Date | 0311011529/18/02/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Aug/202122/7 dated 13.08.2021against advance authorization No.<br>0310826282 dated 10.01.2019, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details<br>given below or as applied by the firm, whichever is less:<br>Sl. No. Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>1<br>SELAMECTIN (6 PERCENT SPOT<br>ON 0.25 ML TUBE)<br>100 Number<br>1<br>SELAMECTIN<br>1.53 gram<br>2<br>SELAMECTIN (6 PERCENT SPOT<br>ON 0.75 ML TUBE)<br>100 Number<br>1<br>SELAMECTIN<br>4.59 gram<br> <br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 116 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | ENCUBE ETHICALS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00359473AM22 |
| RA File Number | 03AX04001229 AM22 |
| Licence No and<br>Date | 0311011469/18/02/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to call for following information/documents<br>from the firm: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
66
UDIN00236046AM23
-
i. Description of all Excipients shown in items to be imported may be furnished as per their chemical name.
-
ii. Details of Packaging Material may be furnished.
-
iii. Copy of Master Batch Formula for export item indicating net content of inputs in each export.
| Case No. | 117 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | TIDE INDUSTRIES |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00359641AM22 |
| RA File Number | 34AX04000278 AM22 |
| Licence No and<br>Date | 3411001821/18/02/2022 |
| Norms Committee Decision:<br>Deferred for comments of TE. | |
| Case No. | 118 / NC/3/MEET/Sep/202223/9 |
| Case Status | Case Deferred |
| Party Name | KUBO COMBUSTION EFFICIENCY CHEMICALS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00359704AM22 |
| RA File Number | 03AX04001024 AM22 |
| Licence No and<br>Date | 0311011564/18/02/2022 |
| Norms Committee Decision:<br>Deferred for comments of TE. | |
| Case No. | 119 / NC/3/MEET/Sep/202223/9 |
| Case Status | Case Deferred |
| Party Name | MAKCUR LABORATORIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00359728AM22 |
| RA File Number | 08AX04000474 AM22 |
| Licence No and<br>Date | 0811004112/18/02/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to call for following information/documents<br>from the firm: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
67
UDIN00236046AM23
- i. COA of import item from foreign supplier showing Actual Potency of import item.
ii Wastage claimed in each export product.
| Case No. | 120 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | DEEPAK NITRITE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00359783AM22 |
| RA File Number | 34AX04000191 AM22 |
| Licence No and<br>Date | 3411001829/18/02/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to call for following information/documents<br>from the firm:<br>Calculation for the requirement of inputs for the manufacture of export item, giving chemical reaction<br>and molecular weight of reactants & products, indicating yield with justification.<br>i.<br>Value of by product/s obtained in the chemical reaction, if any, giving invoice copy.<br>ii. |
| Case No. | Case No. | 121 / NC/3/MEET/Sep/202223/9 | 121 / NC/3/MEET/Sep/202223/9 | 121 / NC/3/MEET/Sep/202223/9 | 121 / NC/3/MEET/Sep/202223/9 | 121 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00363471AM22 | |||||
| RA File Number | 03AX04000968 AM22 | |||||
| Licence No and<br>Date | 0311011657/22/02/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
68
UDIN00236046AM23
2 Piperazine Anhydrous 0.390 kg
| 2 | Piperazine Anhydrous | 0.390 kg | ||||||||||
| RA concerned may | take further necessary action as per above decision of NC. | |||||||||||
| Case No. | 122 / NC/3/MEET/Sep/202223/9 | |||||||||||
| Case Status | Case Approved | |||||||||||
| Party Name | J B CHEMICALS AND PHARMACEUTICALS LIMITED | |||||||||||
| Meeting Number and<br>Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||||
| HQ File Number | HQRNORM APPLY 00363091AM22 | |||||||||||
| R | A File Number | 03AX04001339 AM22 | ||||||||||
| L | icence No and Date | 0311011646/22/02/2022 | ||||||||||
| N<br>T<br>i<br>0<br>g | orms Committee Decision: | |||||||||||
| he Committee considered the case as<br>mport item in Meeting No.NC/3/ME | per agend<br>ET/May/ | a and t<br>202223/ | aking cue from earlier decision for same ex<br>3 dated 27.05.2022against advance auth | port product /<br>orization No. | ||||||||
| 310814635 dated 14.07.2017, it wa<br>iven below or as applied by the firm, w | s decided<br>hichever i | to ratify<br>s less: | adhoc norms under Para 4.07 of HBP Vol. I<br> | as per details | ||||||||
| Sl. No. | Export product | Qty. | Sl. No. | Import items | Qt | . | ||||||
| 1 | ||||||||||||
| Benzydamine<br>Hydrochloride<br>An<br>Cetylpyridinium<br>Chloride<br>Ant<br>Inflammatory And Antiseptic Lozenge | d<br>i-<br>s | 1000<br>Number | 1 | Benzydamine<br>Hydrochloride | 3.06 gram | |||||||
| <br>Sugar Free and(all other flavours. Each | ||||||||||||
| <br>lozenge | <br> <br>contains<br>(i)<br>Benzydamine | 2 | Cetylpyridinium Chloride | 1.356 gram | ||||||||
| <br>Hydroch | <br> <br>loride-3mg (ii) Cetylpyridinium | |||||||||||
| Chloride | - 1.33mg (iii) Isomalt ST-M - | 3 | Isomalt ST-M | 2586.00 gram | ||||||||
| 2586mg<br>14.778 | . Net content (i) 33.333 Kgs (ii)<br>Kgs (iii) 28733.356 Kgs.) | |||||||||||
| 2 | Benzyda | mine<br>Hydrochloride,<br>2,4- | 1000 | 4 | Benzydamine | 3.06 gram | ||||||
| Dichloro<br>Hydroch | benzyl Alcohol And Lidocaine<br>loride<br>Anaesthetic,<br>Anti- | Number | Hydrochloride | |||||||||
| Inflammatory,(Anti-Bacterial Lozenges<br>Sugar Free. Each lozenge contains (i)<br>Benzydamine Hydrochloride - 3mg (ii)<br>Isomalt ST-M- 2586mg. Net content (i)<br>21.333 Kgs. (ii) 18389.439 Kgs.) | 5 | Isomalt ST-M | 2586.00 gram |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
69
UDIN00236046AM23
| 6<br>Benzydamine<br>Hydrochloride<br>3.06 gram<br>3<br>Benzydamine<br>Hydrochloride<br>Anti-<br>Inflammatory Lozenges Sugar Free.<br>Each lozenge contains (i) Benzydamine<br>Hydrochloride-(3mg (ii) Isomalt ST-M -<br>2586mg. Net content (i) 12 Kgs. (ii)<br>10344 Kgs.)<br>1000<br>Number<br>7<br>Isomalt ST-M<br>2586.00 gram<br>8<br>Cetylpyridinium Chloride 1.356 gram<br>4<br>Cetylpyridinium<br>Chloride<br>And<br>Bromhexine Hydrochloride Antiseptic<br>Lozenges Sugar Free and all other<br>flavours.(Each<br>lozenge<br>contains<br>(i)<br>Cetylpyridinium Chloride - 1.33mg (ii)<br>Isomalt ST-M - 2586 mg. Net content (i)<br>13.333 Kg (ii) 25924.878 Kg)<br>1000<br>Number<br>9<br>Isomalt ST-M<br>2586.00 gram<br>10<br>Cetylpyridinium Chloride 1.02 gram<br>5<br>Cetylpyridinium<br>Chloride<br>And<br>Benzydamine Hydrochloride Antiseptic<br>Lozenges Suger Free. Each lozenge<br>contains((i) Cetylpyridinium Chloride-<br>1mg (ii) Isomalt ST-M - 2586mg. Net<br>content (i) 5.22 Kg (ii) 13498.92 Kg)<br>1000<br>Number<br>11<br>Isomalt ST-M<br>2586.00 gram<br> <br>RA concerned may take further necessary action as per above decision of NC. | 3 | Benzydamine<br>Hydrochloride<br>Anti-<br>Inflammatory Lozenges Sugar Free.<br>Each lozenge contains (i) Benzydamine<br>Hydrochloride-(3mg (ii) Isomalt ST-M -<br>2586mg. Net content (i) 12 Kgs. (ii)<br>10344 Kgs.) | <br> <br> <br> <br>1000<br>Number | 6 | Benzydamine<br>Hydrochloride | 3.06 gram |
|---|---|---|---|---|---|---|
| 7 | Isomalt ST-M | 2586.00 gram | ||||
| 4 | Cetylpyridinium<br>Chloride<br>And<br>Bromhexine Hydrochloride Antiseptic<br>Lozenges Sugar Free and all other<br>flavours.(Each<br>lozenge<br>contains<br>(i)<br>Cetylpyridinium Chloride - 1.33mg (ii)<br>Isomalt ST-M - 2586 mg. Net content (i)<br>13.333 Kg (ii) 25924.878 Kg) | <br> <br> <br> <br> <br> <br>1000<br>Number | 8 | Cetylpyridinium Chloride | 1.356 gram | |
| 9 | Isomalt ST-M | 2586.00 gram | ||||
| 5 | Cetylpyridinium<br>Chloride<br>And<br>Benzydamine Hydrochloride Antiseptic<br>Lozenges Suger Free. Each lozenge<br>contains((i) Cetylpyridinium Chloride-<br>1mg (ii) Isomalt ST-M - 2586mg. Net<br>content (i) 5.22 Kg (ii) 13498.92 Kg) | <br> <br> <br> <br> <br>1000<br>Number | 10 | Cetylpyridinium Chloride | 1.02 gram | |
| 11 | Isomalt ST-M | 2586.00 gram |
| Case No. | 123 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | DHANUKA LABORATORIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00364287AM22 |
| RA File Number | 05AX04001048 AM22 |
| Licence No and<br>Date | 0511010134/23/02/2022 |
| Norms Committee Decision:<br>Deferred for comments of TE. |
| Case No. | 124 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | MEGHMANI FINECHEM LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00364297AM22 |
| RA File Number | 34AX04000289 AM22 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
70
UDIN00236046AM23
Licence No and 3411001842/23/02/2022 Date Norms Committee Decision:
Deferred for comments of TE.
| Licence No and | Licence No and | 3411001842/23/02/2022 | 3411001842/23/02/2022 | 3411001842/23/02/2022 | 3411001842/23/02/2022 | 3411001842/23/02/2022 | 3411001842/23/02/2022 | 3411001842/23/02/2022 | 3411001842/23/02/2022 |
|---|---|---|---|---|---|---|---|---|---|
| Date | |||||||||
| Norms Committee<br>Dfd f | Decision:<br>t f TE | ||||||||
| eerre or commens o . | |||||||||
| Case No. | 125 / NC/3/MEET/Sep/202223/9 | ||||||||
| Case Status | Case Approved | ||||||||
| Party Name | MERIDIAN ENTERPRISES PRIVATE LIMITED | ||||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||||
| HQ File Number | HQRNORM APPLY 00364380AM22 | ||||||||
| RA File Number | 03AX04001359 AM22 | ||||||||
| Licence No and | |||||||||
| Date | 0311011694/23/02/2022 | ||||||||
| Norms Committee | Decision: | ||||||||
| The Committee co<br>i i i | nsidered the case as per agenda and taking cue from earlier decision for same export product /<br>i NNC/3/MEET/S/202223/8 dtd 23092022i d hii N | ||||||||
| mport tem n<br>0311005561 dated | eetng o.**ep ae ..**aganst avance autorzaton o.<br>23072021it was decided to ratify adhoc norms under Para 407 of HBP Vol I as per | ||||||||
| <br>details given below | .., . .<br>or as applied by the firm, whichever is less: | ||||||||
| Export product<br>Qty.<br>Sl. No. Import items<br>Qty. | |||||||||
| Qty. | Sl. No. | Import items | Qty. | ||||||
| lii<br>hi<br>l<br>i | lii hli | l | |||||||
| Dequanum<br> <br>(Dequadin Oral | orde<br>Ora<br>Pant<br>Paint) 25 ML Bottel | 1 Number | 1 | Dequanum Corde | 127.07 mg / Botte | ||||
| <br>(Each<br>ml<br>c | .<br>ontains:<br>Dequalinium | ||||||||
| <br>Choride 0.5 p | <br>ercent ((Dequalinium | ||||||||
| Chloride Oral<br>Paint) 25 M | Paint (Dequadin Oral<br>L Bottle. (Each ml | ||||||||
| contains: Dequ<br> | alinium Chloride 0.5<br> | ||||||||
| percent (net c<br> | ontent of Input per<br> | ||||||||
| ml=5mg,Net co<br>125mg Total net | ntent per 25ml bottle =<br>content = 2.597 kgs)) | ||||||||
| <br>RA concerned may take further necessary action as per above decision of NC. | |||||||||
| C | ase No. | 126 / NC/3/MEET/Sep/202223/9 | |||||||
| C | ase Status | Case Approved | |||||||
| P | arty Name | KAIRAV CHEMOFA | RBE IND | USTRIE | S LIMITED | ||||
| M<br>a | eeting Number<br>nd Date | NC/ 3/ MEET/ Sep/ 2 | 02223/ 9 a | nd 07/10 | /2022 | ||||
| H | Q File Number<br>HQRNORM APPLY | 00365021 | AM22 |
| Case No. | 126 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | KAIRAV CHEMOFARBE INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00365021AM22 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
71
UDIN00236046AM23
| RA File Number<br>03AX04001397 AM22 | ||
|---|---|---|
| Licence No and<br>Date<br>0311011707/23/02/2022 | ||
| Norms Committee Decision: | ||
| The Committee considered the case as per agenda and taking cue from earlier decision for same | export product / | |
| import item in Meeting No.NC/3/MEET/Feb/202122/14dated21.02.2022 against advance authorization No. | ||
| 0310831861dated27.09.2019, it was decided to ratify adhoc norms under Para 4.07 of HBP | Vol. I as per | |
| details given below or as applied by the firm, whichever is less: | ||
| Export product<br>Qty.<br>Sl. No. Import items | Qty. | |
| ACETONITRILE<br>(Purity<br>Min.<br>99.9%,<br>350 MT<br>1<br>ACETONITRILE – LOW | 416.51 MT | |
| Moisture less than 500 PPM)<br>PURITY (Purity 98%) | ||
| <br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 127 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | KUSUMA PHARMA |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00365147AM22 |
| RA File Number | 03AX04001369 AM22 |
| Licence No and<br>Date | 0311011710/23/02/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No. | 128 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | AARTI DRUGS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00365148AM22 |
| RA File Number | 03AX04001134 AM22 |
| Licence No and<br>Date | 0311011711/23/02/2022 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
72
UDIN00236046AM23
data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. | |
|---|---|---|---|---|---|
| Ciprofloxacin | Hydrochloride | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||||
| 2 | Piperazine Anhydrous | 0.390 kg |
| Case No. | Case No. | 129 / NC/3/MEET/Sep/202223/9 | 129 / NC/3/MEET/Sep/202223/9 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Case Status | Case Approved | ||||||||
| Party Name | IPCA LABORATORIES | LIMITED | |||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||||
| HQ File Number | HQRNORM APPLY 00365876AM22 | ||||||||
| RA File Number | 03AX04001137 AM22 | ||||||||
| Licence No and<br>Date | 0311011718/24/02/2022 | ||||||||
| Norms Committee Decision: | |||||||||
| The Committee considered the case as per | agenda | and taking cue from earlier decision for | same export product / | ||||||
| import item in Meeting No.12/82-ALC4/2018 dated 12.12.2018against advance authorization No.0310820257 | |||||||||
| dated 04.04.2018, | it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | ||||||||
| or | as applied by the firm, whichever is less: | ||||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | |||||
| METOPROLOL SUCCINATE | 1 kg | 1 | Para Methoxy Ethyl Phenol (or) | 0.7955 kg | |||||
| 4- Methoxy Ethyl Phenol | |||||||||
| 2 | Epichlorohydrine | 0.6179 kg | |||||||
| 3 | Succinic Acid | 0.4508 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
73
UDIN00236046AM23
4 Mono Isopropyl Amine 0.6285 kg
| Case No.<br>130 / NC/3/MEET/Sep/202223/9 | |||
|---|---|---|---|
| Case Status<br>Case Approved | |||
| Party Name<br>AARTI DRUGS LIMITED | |||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||
| HQ File Number<br>HQRNORM APPLY 00365877AM22 | |||
| RA File Number<br>03AX04001350 AM22 | |||
| Licence No and<br>Date<br>0311011719/24/02/2022 | |||
| Norms Committee Decision: | |||
| The Committee considered the case as per agenda and on | the basis GST data furnished by the firm and comparative | ||
| data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below | |||
| or as applied by the firm, whichever is less: | |||
| Export product<br>Qty.<br>Sl. No. | Import items | Qty. | |
| 1<br>Ciprofloxacin<br>Hydrochloride<br>1 kg | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro- | 1.240 kg | |
| BP/EP/USP (Ciprofloxacin) | 5Fluorobenzoyl) Acrylate | ||
| 2 | Piperazine Anhydrous | 0.390 kg | |
| RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 131 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00366482AM22 |
| RA File Number | 05AX04001055 AM22 |
| Licence No and<br>Date | 0511010494/24/02/2022 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
74
UDIN00236046AM23
Deferred for comments of TE.
| Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. |
|---|---|---|---|---|---|---|---|---|
| Case No. | 132 / NC/3/MEET/Sep/202223/9 | |||||||
| Case Status | C Ad | |||||||
| ase tatus | ase pprove | |||||||
| P | arty Name | ETERNIS FINE CHE | MICALS | LIMITE | D | |||
| M<br>a | eeting Number | |||||||
| nd Date | NC/ 3/ MEET/ Sep/ 2 | 2223/ 9 | nd 07/1 | /2022 | ||||
| H | Q File Number | HQRNORM APPLY | 00365875 | AM22 | ||||
| R | A File Number | 03AX04001138 AM2 | 2 | |||||
| L<br>D | icence No and<br>ate | 0311011717/24/02/20 | 22 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda it was decided to ratify adhoc norms under Para 4.07 of HBP Vol.<br>I as per details given below or as applied by the firm, whichever is less: | orms Committee Decision: | |||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||||
| AMYL CINNA | MIC ALDEHYDE | 1 kg | 1 | HEPTALDEHYDE | 0.577 kg | |||
| 2 | 2 k | |||||||
| BENZLDEHYDE | 0.9 g | |||||||
| 3 | METHANOL | 0.010 kg | ||||||
| <br>RA concerned may take further necessary action a | ||||||||
| s per above decision of NC. | ||||||||
| Case No. | 133 / NC/3/MEET/Sep/202223/9 | |||||||
| Case Status | Case Deferred | |||||||
| Party Name | INTAS PHARMACEUTICALS LIMITED | |||||||
| Meeting Number | NC/ 3/ MEET/ S/ 202223/ 9 d 07/10/2022 | |||||||
| and Date | ep an | |||||||
| HQ File Number | HQRNORM APPLY 00367536AM22 | |||||||
| RA File Number | 08AX04000483 AM22 | |||||||
| Licence No and | 0811004214/25/02/2022 | |||||||
| Date | ||||||||
| Norms Committee | Decision: | |||||||
| Dfd f | f TE | |||||||
| eerre or comm | nts o . | |||||||
| Case No. | 134 / NC/3/MEET/Sep/202223/9 |
| Case No. | 133 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | INTAS PHARMACEUTICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00367536AM22 |
| RA File Number | 08AX04000483 AM22 |
| Licence No and<br>Date | 0811004214/25/02/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
Case No. 134 / NC/3/MEET/Sep/202223/9
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
75
UDIN00236046AM23
| Case Status | Case Deferred |
|---|---|
| Party Name | INTAS PHARMACEUTICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00367541AM22 |
| RA File Number | 08AX04000478 AM22 |
| Licence No and<br>Date | 0811004216/25/02/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No. | 135 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | INTAS PHARMACEUTICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00367543AM22 |
| RA File Number | 08AX04000490 AM22 |
| Licence No and<br>Date | 0811004217/25/02/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No.<br>136 / NC/3/MEET/Sep/202223/9 | ||||||
|---|---|---|---|---|---|---|
| Case Status<br>Case Approved | ||||||
| Party Name<br>HARMAN FINOCHEM LIMITED | ||||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||
| HQ File Number<br>HQRNORM APPLY 00367120AM22 | ||||||
| RA File Number<br>03AX04001428 AM22 | ||||||
| Licence No and<br>Date<br>0311011779/25/02/2022 | ||||||
| Norms Committee Decision: | ||||||
| The Committee considered the case as per agenda and | it was decided to ratify adhoc norms under Para 4.07 of HBP | |||||
| Vol. I as per details given below or as applied by the firm, whichever is less: | ||||||
| Sl. No. Export Product | Qty. | Sl. No. | Import Items | Qty. | ||
| METFORMIN<br>500MG<br>TABLETS((Each<br>1 | <br>1 Number | 1 | DICYANDIAMIDE | 289.17 mg | ||
| Metformin 500mg Tablet contains Metformin | ||||||
| HCL 500mg) equivalent to:- Dicyandiamide |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
76
UDIN00236046AM23
| 289.170 mg, DMF 188.700 mg. Total Net wt of | 2 | DMF | 188.70 mg | ||
|---|---|---|---|---|---|
| Export 68250 kgs (Cross SION Norms of | |||||
| Metformin<br>HCL<br>SION<br>No.A290<br>& | |||||
| Tablets/Capsules SION No A412.)) | |||||
| 2 | METFORMIN<br>850MG<br>TABLETS((Each | 1 Number | 3 | DICYANDIAMIDE | 491.589 mg |
| Metformin 850mg Tablet contains Metformin | |||||
| HCL 850mg) equivalent to:- Dicyandiamide | |||||
| 491.589 mg, DMF 320.790 mg. Total Net wt of | 4 | DMF | 320.79 mg | ||
| Export 6291.700 kgs (Cross SION Norms of | |||||
| Metformin<br>HCL<br>SION<br>No.A290<br>& | |||||
| Tablets/Capsules SION No A412.)) | |||||
| 3 | METFORMIN<br>1000MG<br>TABLETS((Each | <br>1 Number | 5 | DICYANDIAMIDE | 578.34 mg |
| Metformin 1000mg Tablet contains Metformin | |||||
| HCL 1000mg) equivalent to:-Dicyandiamide | |||||
| 578.340 mg, DMF 377.400 mg. Total Net wt of | 6 | DMF | 377.40 mg | ||
| Export 6378.000 kgs (Cross SION Norms of | |||||
| Metformin<br>HCL<br>SION<br>No.A290<br>& | |||||
| Tablets/Capsules SION No A412.)) |
| Case No.<br>137 / NC/3/MEET/Sep/202223/9 | ||||||
|---|---|---|---|---|---|---|
| Case Status<br>Case Approved | ||||||
| Party Name<br>VIVIMED LIFE SCIENCES PRIVATE LIMITED | ||||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||
| HQ File Number<br>HQRNORM APPLY 00367797AM22 | ||||||
| RA File Number<br>04AX04000240 AM22 | ||||||
| Licence No and<br>Date<br>0411002766/25/02/2022 | ||||||
| Norms Committee Decision: | ||||||
| The Committee considered the case as per agenda and taking cue | from earlier decision for same | export product / | ||||
| import item in Meeting No.6/82-ALC4/2019 dated 16.08.2019against advance authorization No.0910067740 dated | ||||||
| 03.07.2019, it was decided to ratify adhoc norms under | Para 4.07 of HBP Vol. I as per details given below or as | |||||
| applied by the firm, whichever is less: | ||||||
| Sl. No. Export Product<br>Qty. | Sl. No. | Import Items | Qty. | |||
| 1<br>Losartan Potassium Tablets<br>1 Number Tablet | 1 | Losartan Potassium or Losartan | <br>25.5 mg | |||
| USP - 25MG-90s | Potassium USP |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
77
UDIN00236046AM23
| 2 | Mannitol (Pearlitol 160C) | 101.9 mg | ||||
|---|---|---|---|---|---|---|
| 3 | Microcrystalline Cellulose | 40.5 mg | ||||
| 4 | Croscarmellose Sodium | 7.19 mg | ||||
| 5 | Povidone K | 3.61 mg | ||||
| 6 | Magnesium Stearate | 1.8 mg | ||||
| 7 | Opadry White | 3.6 mg | ||||
| 2 | Losartan Potassium Tablets<br>USP - 25MG-1000s | <br>1 Number Tablet | 8 | Losartan Potassium or Losartan<br>Potassium USP | <br>25.5 mg | |
| 9 | Mannitol (Pearlitol 160C) | 101.9 mg | ||||
| 10 | Microcrystalline Cellulose | 40.5 mg | ||||
| 11 | Croscarmellose Sodium | 7.19 mg | ||||
| 12 | Povidone K | 3.61 mg | ||||
| 13 | Magnesium Stearate | 1.8 mg | ||||
| 14 | Opadry White | 3.6 mg | ||||
| 3 | Losartan Potassium Tablets<br>USP - 50MG-90s | <br>1 Number Tablet | 15 | Losartan Potassium or Losartan<br>Potassium USP | <br>51 mg | |
| 16 | Mannitol (Pearlitol 160C) | 203.8 mg | ||||
| 17 | Microcrystalline Cellulose | 81.0 mg | ||||
| 18 | Croscarmellose Sodium | 14.38 mg | ||||
| 19 | Povidone K | 7.22 mg | ||||
| 20 | Magnesium Stearate | 3.6 mg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
78
UDIN00236046AM23
| 21 | Opadry White | 7.2 mg | ||||
|---|---|---|---|---|---|---|
| 4 | Losartan Potassium Tablets<br>USP - 50MG-1000s | <br>1 Number Tablet | 22 | Losartan Potassium or Losartan<br>Potassium USP | <br>51 mg | |
| 23 | Mannitol (Pearlitol 160C) | 203.8 mg | ||||
| 24 | Microcrystalline Cellulose | 81.0 mg | ||||
| 25 | Croscarmellose Sodium | 14.38 mg | ||||
| 26 | Povidone K | 7.22 mg | ||||
| 27 | Magnesium Stearate | 3.6 mg | ||||
| 28 | Opadry White | 7.2 mg | ||||
| 5 | Losartan Potassium Tablets<br>USP - 100MG-90s | <br>1 Number Tablet | 29 | Losartan Potassium or Losartan<br>Potassium USP | <br>102 mg | |
| 30 | Mannitol (Pearlitol 160C) | 407.6 mg | ||||
| 31 | Microcrystalline Cellulose | 162 mg | ||||
| 32 | Croscarmellose Sodium | 28.76 mg | ||||
| 33 | Povidone K | 14.44 mg | ||||
| 34 | Magnesium Stearate | 7.2 mg | ||||
| 35 | Opadry White | 14.4 mg | ||||
| 6 | Losartan Potassium Tablets<br>USP - 100MG-1000s | <br>1 Number Tablet | 36 | Losartan Potassium or Losartan<br>Potassium USP | <br>102 mg | |
| 37 | Mannitol (Pearlitol 160C) | 407.6 mg | ||||
| 38 | Microcrystalline Cellulose | 162 mg | ||||
| 39 | Croscarmellose Sodium | 28.76 mg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
79
UDIN00236046AM23
| 40 | Povidone K | 14.44 mg | ||
|---|---|---|---|---|
| 41 | Magnesium Stearate | 7.2 mg | ||
| 42 | Opadry White | 14.4 mg |
| Case No. | 138 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | INDOCO REMEDIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00367121AM22 |
| RA File Number | 03AX04001357 AM22 |
| Licence No and<br>Date | 0311011780/25/02/2022 |
| Norms Committee Decision:<br>Deferred for comments of TE. |
| Case No. | Case No. | 139 / NC/3/MEET/Sep/202223/9 | 139 / NC/3/MEET/Sep/202223/9 | 139 / NC/3/MEET/Sep/202223/9 | 139 / NC/3/MEET/Sep/202223/9 | 139 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | INDO AMINES LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00367123AM22 | |||||
| RA File Number | 03AX04001414 AM22 | |||||
| Licence No and<br>Date | 0311011782/25/02/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Jul/202122/4 dated 15.07.2021against advance authorization No.<br>0311001846 dated 01.03.2021, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details<br>given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
80
UDIN00236046AM23
LAURYL AMINE OR IAL LAD 1 kg 1 LAURIC ACID 1.48 kg
| Case No. | Case No. | 140 / NC/3/MEET/Sep/202223/9 | 140 / NC/3/MEET/Sep/202223/9 | 140 / NC/3/MEET/Sep/202223/9 | 140 / NC/3/MEET/Sep/202223/9 | 140 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | AARTI DRUGS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00367127AM22 | |||||
| RA File Number | 03AX04001176 AM22 | |||||
| Licence No and<br>Date | 0311011786/25/02/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and on the basis GST data furnished by the firm and comparative<br>data from other firms, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below<br>or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate<br>1.240 kg<br>Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin)<br>1 kg<br>2<br>Piperazine Anhydrous<br>0.390 kg<br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Ciprofloxacin<br>Hydrochloride<br>BP/EP/USP (Ciprofloxacin) | <br>1 kg | 1 | Ethyl 3 Cyclopropylamino-2(2,4 Dichloro-<br>5Fluorobenzoyl) Acrylate | 1.240 kg | ||
| 2 | Piperazine Anhydrous | 0.390 kg | ||||
| s per above decision of NC. |
| Case No. | 141 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | AURORE LIFE SCIENCES PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00367304AM22 |
| RA File Number | 09AX04000261 AM22 |
| Licence No and<br>Date | 0911002566/25/02/2022 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
81
UDIN00236046AM23
Deferred for comments of TE.
| Case No. | 142 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | AASHA BIOCHEM |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00370268AM22 |
| RA File Number | 10AX04000065 AM22 |
| Licence No and<br>Date | 1011000912/28/02/2022 |
| Norms Committee Decision:<br>Deferred for comments of TE. |
| Case No. | Case No. | 143 / NC/3/MEET/Sep/202223/9 | 143 / NC/3/MEET/Sep/202223/9 | 143 / NC/3/MEET/Sep/202223/9 | 143 / NC/3/MEET/Sep/202223/9 | 143 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | SONGWON SPECIALTY CHEMICALS - INDIA PRIVATE LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00370611AM22 | |||||
| RA File Number | 34AX04000302 AM22 | |||||
| Licence No and<br>Date | 3411001872/28/02/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/May/202223/3dated27.05.2022 against advance authorization No.<br>3410045298dated18.07.2019, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per<br>details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Dimethyl Oxalate<br>1.25 kg<br>2<br>Sodium Methoxide Powder<br>0.856 kg<br>3<br>Sodium Methoxide Solution ( 30 % ) /Sodium<br>Methylate Solution ( 30 % )<br>1.52 kg<br>4<br>Dimethylformamide<br>0.55 kg<br>EDOT<br>(3,4-Ethylenedioxythiophene)<br>(Other Organo - Sulphur<br>Compounds )<br>1 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| EDOT<br>(3,4-Ethylenedioxythiophene)<br>(Other Organo - Sulphur<br>Compounds ) | <br>1 kg | 1 | Dimethyl Oxalate | 1.25 kg | ||
| 2 | Sodium Methoxide Powder | 0.856 kg | ||||
| 3 | Sodium Methoxide Solution ( 30 % ) /Sodium<br>Methylate Solution ( 30 % ) | <br>1.52 kg | ||||
| 4 | Dimethylformamide | 0.55 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
82
UDIN00236046AM23
| 5<br>1,2-Dichloroethane / Ethylene Dichloride<br>1.835 kg<br>6<br>Sulfolane<br>0.26 kg<br>7<br>Sodium Sulphide ( 60 % min.) / Sodium Sulfide (<br>60% min)<br>1.458 kg<br>8<br>Methyl Monochloro Acetate<br>2.454 kg<br> <br>RA concerned may take further necessary action as per above decision of NC. | 5 | 1,2-Dichloroethane / Ethylene Dichloride | 1.835 kg | ||
|---|---|---|---|---|---|
| 6 | Sulfolane | 0.26 kg | |||
| 7 | Sodium Sulphide ( 60 % min.) / Sodium Sulfide (<br>60% min) | <br>1.458 kg | |||
| 8 | Methyl Monochloro Acetate | 2.454 kg |
| Case No. | 144 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | DEEPAK NITRITE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00370625AM22 |
| RA File Number | 34AX04000311 AM22 |
| Licence No and<br>Date | 3411001873/28/02/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to call for following information/documents from the<br>firm:<br>By Product obtained during the reaction for manufacturing of export item giving its value with invoices. |
| Case No. | 145 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | LAXMI ORGANIC INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00370690AM22 |
| RA File Number | 03AX04000957 AM22 |
| Licence No and<br>Date | 0311011997/28/02/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP<br>Vol. I as per details given below or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
83
UDIN00236046AM23
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| METHYL ACETOACETATE (ACETO<br>ACETIC METHYL ESTER) | <br>1 kg | 1 | Acetic Acid | 1.209 kg<br>(with 25% wastage |
| 2 | Methanol | 0.284 kg (with 3% wastage) |
| Case No. | Case No. | Case No. | 146 / NC/3/MEET/Sep/202223/9 | 146 / NC/3/MEET/Sep/202223/9 | 146 / NC/3/MEET/Sep/202223/9 | 146 / NC/3/MEET/Sep/202223/9 | 146 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|---|
| Case Status | Case Approved | ||||||
| Party Name | MAIVA PHARMA PRIVATE LIMITED | ||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||
| HQ File Number | HQRNORM APPLY 00369904AM22 | ||||||
| RA File Number | 07AX04000402 AM22 | ||||||
| Licence No and<br>Date | 0711003263/28/02/2022 | ||||||
| Norms Committee Decision:<br>The Committee considered case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP Vol.<br>I as per details given below or as applied by the firm, whichever is less:<br>Sl. No. Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Sterile Water for Injection 10mL<br>Vial(Sterile Water for injection,<br>filled in 10mL Vial and capped<br>with<br>13mm<br>GreySerum<br>ChlorobutyI Rubber Stopper &<br>13mm white colour Matte finish<br>Seals)<br>1 Number<br>1<br>13FO LQ 3766 white<br>MATTE TOP (13mm<br>white<br>Color<br>Matte<br>Seals)<br>Relevant as per packing<br>policy<br>with<br>Accountability clause<br>Sodium Chloride Injection USP<br>90mg per 10mL Vial.(10mL<br>Vial - filled with 90mg of<br>Sodium Chloride as bulk drug<br>2<br>1 Number<br>2<br>13FO LQ 3769 BLUE<br>MATTE TOP (13mm<br>Blue<br>Color<br>Matte<br>Seals)<br>Relevant as per packing<br>policy<br>with<br>Accountability clause | |||||||
| Sl. No. <br>1<br>2 | Export product<br> | Qty. | Sl. No. | Import items | Qty. | ||
| Sterile Water for Injection 10mL<br>Vial(Sterile Water for injection,<br>filled in 10mL Vial and capped<br>with<br>13mm<br>GreySerum<br>ChlorobutyI Rubber Stopper &<br>13mm white colour Matte finish<br>Seals) | <br> <br> <br> <br> <br> <br>1 Number | 1 | 13FO LQ 3766 white<br>MATTE TOP (13mm<br>white<br>Color<br>Matte<br>Seals) | Relevant as per packing<br>policy<br>with<br>Accountability clause | |||
| Sodium Chloride Injection USP<br>90mg per 10mL Vial.(10mL<br>Vial - filled with 90mg of<br>Sodium Chloride as bulk drug | <br> <br> <br> <br>1 Number | 2 | 13FO LQ 3769 BLUE<br>MATTE TOP (13mm<br>Blue<br>Color<br>Matte<br>Seals) | Relevant as per packing<br>policy<br>with<br>Accountability clause |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
84
UDIN00236046AM23
| filled in 10mL Vial and capped | |||||
|---|---|---|---|---|---|
| with<br>13mm<br>GreySerum | |||||
| ChlorobutyI Rubber Stopper & | |||||
| & 13mm Blue colour Matte | |||||
| finish Seals) |
| filled in 10mL Vial and capped<br>with<br>13mm<br>GreySerum<br>ChlorobutyI Rubber Stopper &<br>& 13mm Blue colour Matte<br>finish Seals)<br> <br>RA concerned may take further necessary action as per above decision of NC. | filled in 10mL Via<br>with<br>13mm<br>ChlorobutyI Rubbe<br>& 13mm Blue c<br>finish Seals) | filled in 10mL Via<br>with<br>13mm<br>ChlorobutyI Rubbe<br>& 13mm Blue c<br>finish Seals) | l and capped<br>GreySerum<br>r Stopper &<br>olour Matte | <br> <br> <br> | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case No. | 147 / NC/3/MEET/Sep/202223/9 | |||||||||||||
| Case Status | Case Approved | |||||||||||||
| Party Name | YASHO INDUSTRIES LIMITED | |||||||||||||
| Meeting Number<br> | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||||||
| and Date | ||||||||||||||
| HQ File Number | HQRNORM APPLY 00369996AM22 | |||||||||||||
| RA File Number | 03AX04001474 AM22 | |||||||||||||
| Licence No and<br> | 0311011969/28/02/2022 | |||||||||||||
| Date | ||||||||||||||
| Norms Committee | Decision: | |||||||||||||
| The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/May/202223/4dated17.06.2022 against advance authorization No.<br>0311004509dated10.06.2021, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per | ||||||||||||||
| details given below or as applied by the firm, whichever is less: | ||||||||||||||
| Export Product | Qty. | Sl. No. | Import items | Qty. | ||||||||||
| DI-NONYLATE | D<br>DIPHENYLAMINE | <br>1 kg | 1 | DIPHENYLAMINE | 0.4134 kg | |||||||||
| <br>(YALUB DND) | ||||||||||||||
| 2 | NONENE | 0.4 kg | ||||||||||||
| 3 | ACTIVATED CLAY | 0.05 kg | ||||||||||||
| RA concerned may | take further necessary action as per above decision of NC. | |||||||||||||
| Case No. | 148 / NC/3/MEET/Sep/202223/9 | |||||||||||||
| Case Status | Case Approved | |||||||||||||
| Party Name | SUVEN PHARMACEUTICALS LIMITED | |||||||||||||
| Meeting Number | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||||||
| Case No. | 148 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SUVEN PHARMACEUTICALS LIMITED |
| Meeting Number | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
85
UDIN00236046AM23
| and Date | and Date | |||||
|---|---|---|---|---|---|---|
| HQ File Number | HQRNORM APPLY 00370092AM22 | |||||
| RA File Number | 09AX04000243 AM22 | |||||
| Licence No and<br>Date | 0911002567/28/02/2022 | |||||
| Norms Committee Decision:<br>The Committee considered case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP Vol.<br>I as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>L TERT LEUCINE<br>0.72 kg<br>2<br>ETHYL TRIFLUORO ACETATE<br>0.78 kg<br>3-METHYL-N-<br>(TRIFLUOROACETYL)-L-<br>VALINE(POWDER)<br>1 kg<br>3<br>HEPTANE<br>3.88 kg<br> <br>RA concerned may take further necessary action as per above decision of NC. | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| 3-METHYL-N-<br>(TRIFLUOROACETYL)-L-<br>VALINE(POWDER) | 1 kg | 1 | L TERT LEUCINE | 0.72 kg | ||
| 2 | ETHYL TRIFLUORO ACETATE | 0.78 kg | ||||
| 3 | HEPTANE | 3.88 kg | ||||
| per above decision of NC. |
| Case No. | Case No. | 149 / NC/3/MEET/Sep/202223/9 | 149 / NC/3/MEET/Sep/202223/9 | 149 / NC/3/MEET/Sep/202223/9 | 149 / NC/3/MEET/Sep/202223/9 | 149 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | MERIDIAN ENTERPRISES PRIVATE LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00370234AM22 | |||||
| RA File Number | 03AX04001473 AM22 | |||||
| Licence No and<br>Date | 0311011978/28/02/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Sep/202223/8 dated 23.09.2022against advance authorization No.<br>0311005561 dated 23.07.2021, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per<br>details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>Dequalinium<br>Chloride<br>Oral<br>Paint 1 Number<br>1<br>Dequalinium Chloride<br>127.07 mg /Bottle | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Dequalinium<br>Chloride<br>Oral<br>Paint | 1 Number | 1 | Dequalinium Chloride | 127.07 mg /Bottle |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
86
UDIN00236046AM23
(Dequadin Oral Paint) 25 ML Bottle. (Each ml contains: Dequalinium Chloride 0.5 percent(Dequalinium Chloride Oral Paint (Dequadin Oral Paint) 25 ML Bottle. (Each ml contains: Dequalinium Chloride 0.5 percent (net content of Input per ml=5mg,Net content per 25ml bottle = 125mg Total net content = 2.597 kgs))
| Case No. | 150 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | AUROBINDO PHARMA LTD |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00371439AM22 |
| RA File Number | 09AA04017878 AM22 |
| Licence No and<br>Date | 0911002574/01/03/2022 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and it was decided to call for following information/documents | |
| from the firm: | |
| Consumption coefficient for 1 kg Amoxicilin Bulk.<br>i. | |
| Wastage applied on API for Tablets.<br>ii. | |
| Copy of relevant DML.<br>iii. | |
| iv Copy of Master Batch Formula. |
| Case No. | 151 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | AUROBINDO PHARMA LTD |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00371441AM22 |
| RA File Number | 09AX04000232 AM22 |
| Licence No and<br>Date | 0911002575/01/03/2022 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
87
UDIN00236046AM23
Deferred for comments of TE.
| Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. | Deferred for comments of TE. |
|---|---|---|---|---|---|---|
| Case No. | 152 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Approved | |||||
| Party Name | CLEAN SCIENCE AND TECHNOLOGY LIMITED | |||||
| Meeting Number | ||||||
| and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00371619AM22 | |||||
| RA File Number | 31AX04000082 AM22 | |||||
| Licence No and | ||||||
| Date | 3111001116/01/03/2022 | |||||
| Norms Committee | Decision: | |||||
| The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Mar/202122/16 dated 08.04.2022against advance authorization No.<br>3111000614 dated 12.10.2021, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details | ||||||
| <br>given below or as applied by the firm, whichever is less: | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Al Ail | 1 k | 1 | Phl | 072 k | ||
| cety nsoe | g | eno | . g | |||
| (4 Methoxy Ace | tophenone) | 2 | Methanol | 0.276 kg | ||
| 3 | Acetic Anhydride | 0.755 kg | ||||
| RA concerned may | take further necessary action a | s per above decision of NC. | ||||
| Case No. | 153 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Deferred | |||||
| Party Name | ARENE LIFE SCIENCES PRIVATE LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00371807AM22 | |||||
| RA File Number | 09AX04000256 AM22 | |||||
| Licence No and<br>Date | 0911002585/01/03/2022 | |||||
| N Ci Dii | ||||||
| orms ommttee | ecson: | |||||
| Deferred for comme | nts of TE. | |||||
| Case No. | 153 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | ARENE LIFE SCIENCES PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00371807AM22 |
| RA File Number | 09AX04000256 AM22 |
| Licence No and<br>Date | 0911002585/01/03/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
88
UDIN00236046AM23
| Case No. | 154 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | MICRO LABS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00372524AM22 |
| RA File Number | 07AX04000434 AM22 |
| Licence No and<br>Date | 0711003323/02/03/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.5/82-ALC4/2019 dated 02.08.2019against advance authorization No.3110067352 dated<br>28.03.2019, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as<br>applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>TRANEXAMIC<br>ACID<br>INJECTION<br>1000 MG / 10 ML BP/EP/USP/IP<br>(Net content 228.57 kg) TRANEXAMIC<br>ACID INJECTION 1000 MG / 10 ML<br>BP/EP/USP/IP (Net content 228.57 kg ))<br>1 Number<br>1<br>TRANEXAMIC ACID<br>1100 mg / 10 ml vial<br> <br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 155 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | HIMADRI SPECIALITY CHEMICAL LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00372545AM22 |
| RA File Number | 02AX04000172 AM22 |
| Licence No and<br>Date | 0211002041/02/03/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to call for following information/documents<br>from the firm: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
89
UDIN00236046AM23
-
i. COA report of import item from foreign supplier.
-
ii. By-Product obtained during processing and its value with invoices.
-
iii. Indigenous items to use in process.
| COA report of import item from foreign supplier.<br>i.<br>By-Product obtained during processing and its value with invoices.<br>ii. | COA report of import item from foreign supplier.<br>i.<br>By-Product obtained during processing and its value with invoices.<br>ii. | COA report of import item from foreign supplier.<br>i.<br>By-Product obtained during processing and its value with invoices.<br>ii. | COA report of import item from foreign supplier.<br>i.<br>By-Product obtained during processing and its value with invoices.<br>ii. | COA report of import item from foreign supplier.<br>i.<br>By-Product obtained during processing and its value with invoices.<br>ii. | COA report of import item from foreign supplier.<br>i.<br>By-Product obtained during processing and its value with invoices.<br>ii. | COA report of import item from foreign supplier.<br>i.<br>By-Product obtained during processing and its value with invoices.<br>ii. |
|---|---|---|---|---|---|---|
| <br>Indigenous items to use in process.<br>iii. | ||||||
| Case No. | 156 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Approved | |||||
| Part Name | SUVEN PHARMACEUTICALS LIMITED | |||||
| y | ||||||
| Meetin Number | ||||||
| g<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00372701AM22 | |||||
| RA File Number | 09AX04000259 AM22 | |||||
| Licence No and<br>Date | 0911002597/02/03/2022 | |||||
| Norms Committee Decision: | ||||||
| The Committee co<br>d P 407 f | nsidered the request of firm for fixation of adhoc norms and it was decided to ratify adhoc norms<br>HBP Vl I dtil i bl lid b th fi hih i l | |||||
| un | er ara . o | o. as per | eas gven eow or as appe y e rm, wcever s ess: | |||
| Export produ | ct | Qty. | Sl. No. | Import items | Qty. | |
| 3-METHYL-N | - | 1 kg | 1 | L TERT LEUCINE | 0.72 kg | |
| (TRIFLUOROACETYL)-L-<br>VALINE(POWDER) | ||||||
| 2 | ETHYL TRIFLUORO ACETATE | 0.78 kg | ||||
| 3 | HEPTANE | 3.88 kg | ||||
| RA concerned may | take further necessary action as per above decision of NC. | |||||
| Case No. | 157 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Approved | |||||
| Party Name | SUN PHARMACEUTICAL INDUSTRIES LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00372853AM22 | |||||
| RA File Number | 05AX04001101 AM22 | |||||
| Licence No and | 0511010578/02/03/2022 | |||||
| Date | ||||||
| Norms Committee | Decision: |
| Case No. | 157 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00372853AM22 |
| RA File Number | 05AX04001101 AM22 |
| Licence No and<br>Date | 0511010578/02/03/2022 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
90
UDIN00236046AM23
The Committee considered the case as per agenda and taking cue from earlier decision for same export product / import item in Meeting No. NC/3/MEET/Apr/202223/1 dated 29.04.2022 against advance authorization No. 0511006574 dated 02.12.2021 , it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| Nepafenac Ophthalmic Suspension, 0.1Percent | <br>1 Number | 1 | Nepafenac | 5.1 mg / Vial |
| w/v NEPALACT Sterile Eye Drops, 5ml) | ||||
| (PRANAYAM)((Each ml | ||||
| contains Nepafenac 1.0 mg (Equivalent to | ||||
| 130.000 Gram of Bulk Drug)) |
| Case No.<br>158 / NC/3/MEET/Sep/202223/9 | Case No.<br>158 / NC/3/MEET/Sep/202223/9 | |||||
|---|---|---|---|---|---|---|
| Case Status<br>Case Approved | ||||||
| Party Name<br>SUN PHARMACEUTICAL INDUSTRIES LIMITED | ||||||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||
| HQ File Number<br>HQRNORM APPLY 00372854AM22 | ||||||
| RA File Number<br>05AX04001140 AM22 | ||||||
| Licence No and<br>Date<br>0511010579/02/03/2022 | ||||||
| Norms Committee Decision: | ||||||
| The Committee considered the case as per agenda and it | was decided to ratify adhoc | norms under Para 4.07 of HBP | ||||
| Vol. I as per details given below or as applied by the firm, whichever is less: | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Moxifloxacin HCL and Dexamethasone | <br>38000 | 1 | Moxifloxacin Hydrochloride | 1087.27 Gram | ||
| Sodium Phosphate Eye Drops 0.5%w/v, | ||||||
| 0.1%<br>w/v,<br>5ml<br>(MILFLOX<br>DM, | <br>Number | |||||
| MILFODOX,<br>(MIFLOCO<br>DELTA) | 2 | Dexamethasone | Sodium | 219.45 Gram | ||
| (Each ml contain Moxifloxacin Base | Phosphate | |||||
| 5mg.<br>equi.<br>to<br>Moxifloxacin<br>HCL | ||||||
| 5.45mg. & Dexamethasone Phosphate | ||||||
| 1mg equi. to Dexamethasone Sodium |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
91
UDIN00236046AM23
Phosphate 1.1mg (Equi.to 1035.500gm Moxifloxacin HCL and 209.000gm Dexamethasone Sodium Phosphate ))
| Phosphate 1.1mg (Equi.to 1035.500gm<br>Moxifloxacin HCL and 209.000gm | Phosphate 1.1mg (Equi.to 1035.500gm<br>Moxifloxacin HCL and 209.000gm | Phosphate 1.1mg (Equi.to 1035.500gm<br>Moxifloxacin HCL and 209.000gm | <br> | <br> | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| <br>Dexamethasone Sodium | ||||||||||
| Phosphate )) | ||||||||||
| <br> | ||||||||||
| RA concerned may | take further necessary action as per above decision of NC. | |||||||||
| Case No. | 159 / NC/3/MEET/Sep/202223/9 | |||||||||
| C Stt | C Ad | |||||||||
| ase aus | ase pprove | |||||||||
| Party Name | EMCURE PHARMACEUTICALS LIMITED | |||||||||
| Meeting Number and<br>Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||
| HQ File Number | HQRNORM APPLY 00373052AM22 | |||||||||
| RA File Number | 31AX04000077 AM22 | |||||||||
| Licence No and Da | te | 3111001114/02/03/2022 | ||||||||
| Norms Committee | Decision: | |||||||||
| The Committee co<br> | nsidered the case as per agenda and taking cue from earlier decision for same export product /<br> | |||||||||
| import item in M<br> | eeting No.NC/3/MEET/Jan/202122/13 dated 21.01.2022against advance authorization No.<br> | |||||||||
| 3111000570 dated<br>dtil i bl | 08.09.2021, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per<br>lid b th fi hih i l | |||||||||
| as gven eo | or as appe y e rm, wcever s ess: | |||||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||||||
| CIPROBIOTIC FORT TAB 500MG<br>(CIPROFLOXACIN TABLETS<br>500MG)(EACH FILM COATED TABLET | 1 Number | 1 | CIPROFLOXACIN<br>HYDROCHLORIDE<br>USP | 555.00 mg | ||||||
| CONTAIN<br>:<br>CIPROFLOXACIN | ||||||||||
| HYDROCHLO | RIDE USP EQUIVALENT | |||||||||
| TO CIPROFL | OXACIN 500 MG [NET | |||||||||
| WEIGHT 2577. | 33 KG]) | |||||||||
| RA concerned may | take further necessary action as per above decision of NC. | |||||||||
| Case No. | 160 / NC/3/MEET/Sep/202223/9 | |||||||||
| Case Status | Case Deferred | |||||||||
| Party Name | SRIAM LABS PRIVATE LIMITED | |||||||||
| Meeting Number | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||
| Case No. | 160 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | SRIAM LABS PRIVATE LIMITED |
| Meeting Number | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
92
UDIN00236046AM23
| and Date | |
|---|---|
| HQ File Number | HQRNORM APPLY 00374328AM22 |
| RA File Number | 09AX04000286 AM22 |
| Licence No and<br>Date | 0911002611/03/03/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No.<br>161 / NC/3/MEET/Sep/202223/9 | |||
|---|---|---|---|
| Case Status<br>Case Approved | |||
| Party Name<br>VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED | |||
| Meeting Number<br>and Date<br>NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||
| HQ File Number<br>HQRNORM APPLY 00374384AM22 | |||
| RA File Number<br>03AX04001522 AM22 | |||
| Licence No and<br>Date<br>0311012234/03/03/2022 | |||
| Norms Committee Decision: | |||
| The Committee considered the case as per agenda and | taking cue from earlier decision for same export product / | ||
| import item in Meeting No.5/82-ALC4/2020 dated 09.10.2020against advance authorization No.0310834922 dated | |||
| 18.02.2020, it was decided to ratify adhoc norms under | Para 4.07 of HBP Vol. I as per details given below or as | ||
| applied by the firm, whichever is less: | |||
| Export product<br>Qty. | Sl. No. Import items | Qty. | |
| CLINDAMYCIN HCL CAPSULES-<br>1 Number | 1.<br>CLINDAMYCIN | 173.53 mg | |
| 150MG | HYDROCHLORIDE EP | ||
| <br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 162 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | AROCHEMA INGREDIENTS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00374231AM22 |
| RA File Number | 26AX04000019 AM22 |
| Licence No and<br>Date | 2611000488/03/03/2022 |
| Norms Committee Decision: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
93
UDIN00236046AM23
The Committee considered the case as per agenda and it was decided to call for following information/documents from the firm:
-
i. Complete chemistry, molecular weight and percentage yield.
-
ii. Production / Consumption data duly certified by GST.
-
iii. By-Product obtained during processing and its value with invoices.
| Case No. | 163 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SRIAM LABS PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00374302AM22 |
| RA File Number | 09AX04000287 AM22 |
| Licence No and<br>Date | 0911002609/03/03/2022 |
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Oct/202122/9 dated 15.10.2021 against advance authorization No.<br>0910069160 dated 10.09.2020, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details<br>given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>(R)-2-(Diphenylmethyl)pyrrolidine<br>hydrochloride (RDPH-II)<br>1 kg<br>1<br>D-Proline/R-Proline<br>1.167 kg<br> <br>RA concerned may take further necessary action as per above decision of NC. |
| Case No. | 164 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | MISTAIR HEALTH AND HYGIENE PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00375016AM22 |
| RA File Number | 03AX04001352 AM22 |
| Licence No and<br>Date | 0311012252/04/03/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
94
UDIN00236046AM23
Norms Committee Decision:
Deferred for comments of TE.
| Case No. | 165 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | SAKAR HEALTHCARE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00375600AM22 |
| RA File Number | 08AX04000616 AM22 |
| Licence No and<br>Date | 0811004272/04/03/2022 |
| Norms Committee Decision:<br>**:**The Committee considered the case as per agenda and it was decided to call for following information/documents from<br>the firm:<br>COA of import item from foreign supplier showing potency and wastage claimed on it.<br>i. |
| Case No. | Case No. | 166 / NC/3/MEET/Sep/202223/9 | 166 / NC/3/MEET/Sep/202223/9 | 166 / NC/3/MEET/Sep/202223/9 | 166 / NC/3/MEET/Sep/202223/9 | 166 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | BENZO CHEM INDUSTRIES PVT LTD | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00378292AM22 | |||||
| RA File Number | 03AX04001523 AM22 | |||||
| Licence No and<br>Date | 0311012331/07/03/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.9/82-ALC4/2019 dated 18.10.2019against advance authorization No.0310827603 dated<br>11.03.2019, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as<br>applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>1<br>PROPIOPHENONE<br>0.922 kg<br>2-AMINO<br>-2-PHENYLBUTYRIC<br>ACID SODIUM SALT<br>1 kg<br>2<br>SODIUM CYANIDE (NaCN)<br>0.337 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| 2-AMINO<br>-2-PHENYLBUTYRIC<br>ACID SODIUM SALT | <br>1 kg | 1 | PROPIOPHENONE | 0.922 kg | ||
| 2 | SODIUM CYANIDE (NaCN) | 0.337 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
95
UDIN00236046AM23
| Case No. | 167 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Approved | |||||
| Party Name | APEX DRUG HOUSE | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00378735AM22 | |||||
| RA File Number | 03AX04001508 AM22 | |||||
| Licence No and<br>Date | 0311012345/07/03/2022 | |||||
| Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Oct/202122/10 dated 12.11.2021against advance authorization No.<br> | ||||||
| 0311000381 dated 23.12.2020, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details<br> | ||||||
| given below or as a | pplied by the firm, whichever is less: | |||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| Benzocaine & | Dequalinium Chloride | <br>1 Number | 1. | Dequalinium Chloride BP | 0.255 mg | |
| Lozenges(Benzo<br>Chloride Loze | caine<br>Dequalinium<br>nges (ELIDOL DUO | <br> | ||||
| (Raspberry Flavour) Each Lozenge<br>contains<br>Benzocaine<br>BP<br>10<br>mg,<br>Dequalinium Chloride 0.25 mg Net<br>Content: 1) Dequalinium Chloride BP - | <br> <br> <br> | |||||
| <br>370.3750 GRAMS 2) Benzocaine BP - | <br> | |||||
| <br>Kgs (Indigenous | <br>):22.222 KGS) | |||||
| <br>RA concerned may | take further necessary action as per above decision of NC. | |||||
| Case No. | 168 / NC/3/MEET/Sep/202223/9 | |||||
| Case Status | Case Deferred | |||||
| Party Name | FDC LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00378736AM22 | |||||
| RA Fil Nb | 03AX04001550 AM22 | |||||
| e umer | ||||||
| Li N d | 0311012347/07/03/2022 | |||||
| cence o an | ||||||
| Case No. | 168 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | FDC LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00378736AM22 |
| RA File Number | 03AX04001550 AM22 |
| Licence No and | 0311012347/07/03/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
96
UDIN00236046AM23
Date
Norms Committee Decision:
Deferred for comments of TE.
| Case No. | 169 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | ANANTA MEDICARE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00378768AM22 |
| RA File Number | 05AX04001194 AM22 |
| Licence No and<br>Date | 0511010747/07/03/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No. | 170 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | VIVIMED LIFE SCIENCES PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00378088AM22 |
| RA File Number | 04AX04000278 AM22 |
| Licence No and<br>Date | 0411002806/07/03/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE |
| Case No. | 171 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | PROLIFE BIO-CHEMICAL INDUSTRIES PRIVATE LIMITED |
| Meeting Number and<br>Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00378218AM22 |
| RA File Number | 03AX04001348 AM22 |
| Licence No and Date | 0311012324/07/03/2022 |
| Norms Committee Decision: | |
| The Committee considered the case as per agenda and taking cue from earlier decision for same export product / | |
| import item in Meeting | No.NC/3/MEET/Mar/202122/15 dated 17.03.2022against advance authorization No. |
| 0311000521 dated 01.01.2021, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details | |
| given below or as applied by the firm, whichever is less: |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
97
UDIN00236046AM23
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| METHYLAMINO-4-BROMO | 1 kg | 1. | 1 NITROANTHRAQUINONE | 1.00 kg |
| ANTHRAQUINONE |
| Export product | Qty. | Sl. No. | Import items | Qty. | |||||||||
| METHYLAMIN | O-4-BROMO | 1 kg | 1. | 1 NITROANTHRAQUINONE | 1.00 kg | ||||||||
| ANTHRAQUIN | ONE | ||||||||||||
| RA concerned may | take further necessary action as per above decision of NC. | ||||||||||||
| Case No. | 172 / NC/3/MEET/Sep/202223/9 | ||||||||||||
| Case Status | Case Approved | ||||||||||||
| Party Name | J B CHEMICALS AND PHARMACEUTICALS LIMITED | ||||||||||||
| Meeting Number<br> | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||||||||
| and Date | |||||||||||||
| HQ File Number | HQRNORM APPLY 00378220AM22 | ||||||||||||
| RA File Number | 03AX04000917 AM22 | ||||||||||||
| Licence No and<br>Date | 0311012325/07/03/2022 | ||||||||||||
| Norms Committee | ecision: | ||||||||||||
| The Committee co | nsidered the case as per agenda and taking cue from earlier decision for same export product / | ||||||||||||
| import item in M<br>0310837228 dated | eeting No.NC/3/MEET/Oct/202122/9 dated 15.10.2021 against advance authorization No.<br>16.07.2020, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details | ||||||||||||
| given below or as applied by the firm, whichever is less: | |||||||||||||
| Sl. No. | Export pr | oduct | Qty. | Sl. No. | Import items | Qty. | |||||||
| 1 | B<br> | enzocai<br> | ne<br>and<br>Cetylpyridinium<br>Chloride<br> | <br> <br>1 Num | ber | 1 | Benzocaine | 12.24 mg | |||||
| <br>C | naesthe<br>urrent, | tic Throat Lozenges. Flavours Black<br>Honey Lemon & Other(Flavours. Each | <br> | ||||||||||
| <br>L<br> | <br>ozenge<br> | <br>Contains 12mg Benzocaine. Net content of<br> | <br> | ||||||||||
| B | enzocai | ne - 181.818 Kgs.) | |||||||||||
| 2 | B<br> | enzocaine<br>and<br>Cetylpyridinium<br>Chloride<br> | <br> <br>1 Num | ber | 2 | Benzocaine | 10.20 mg | ||||||
| Anaesthetic Throat Lozenges. Flavours Black<br>Current and Lime & Lemon and Other(Flavours.<br>Each Lozenge contains 10mg Benzocaine. Net<br>content of Benzocaine - 44.944 Kgs.) | <br> <br> | ||||||||||||
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
98
UDIN00236046AM23
| <br> <br> <br> | <br> <br> <br> | <br> <br> <br> | <br> <br> <br> | <br> | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | Benzocai<br>Dextrom<br>Throat L | ne,<br>Cetylpyridinium<br>Chloride<br>And<br>ethorphan<br>Hydrobromide<br>Anaesthetic<br>ozenes(Each Lozene Contains 125m | <br> <br> <br>1 Number | 3 | Benzocaine | 1.275 mg | |||||
| <br>Benzocai | g. g .g<br>ne. Net content of Benzocaine - 23.669 | <br> | |||||||||
| Kgs.) | |||||||||||
| 4 | Life Bra | d Sore Throat & Nasal Conestion Relief | <br>1 Number | 4 | Benzocaine | 1530 m | |||||
| g<br>Extra<br>Strength<br>(Flavours<br>Cherry/Honey<br>&<br>Lemon/Other flavours) Sugar(Free Lozenges. Each<br>Lozenge Contains Bezocaine 15 mg & Isomalt ST-<br>M 2571 Mg. Net Content Benzocaine 13.245 Kgs<br>and Isomalt ST-M - 2270.172 Kgs.) | <br> <br> <br> <br> | . g | |||||||||
| 5 | Isomalt ST-M | 2571.00 mg | |||||||||
| 5 | Personnelle Oral Anesthetic Sore Throat Lozenges<br>Extra Strenght Sugar Free (Flavours Cherry/Honey | <br> <br>1 Number | 6 | Benzocaine | 15.30 mg | ||||||
| <br>Lemon/Other flavours)(Each Lozenge Contains | <br> | ||||||||||
| <br>Bezocain | <br>e 15 mg & Isomalt ST-M 2571 Mg. Net | <br> | 7 | Isomalt ST-M | 2571.00 mg | ||||||
| Content<br> | Benzocaine 13.245 Kgs and Isomalt ST-M -<br> | ||||||||||
| 2270.172 | Kgs.) | ||||||||||
| 6 | Option+O<br> | ral Lozenges Sore Throat & Nasal<br> <br> <br> <br> <br> | <br> <br>1 Number | 8 | Benzocaine | 15.30 mg | |||||
| Congesti<br>Ch/H | on<br>Relief<br>Extra<br>Strenght<br>(Flavours<br> <br>L<br>/Oh<br>flEh | <br> | |||||||||
| erry<br>Lozenge | oney<br>emon<br>ter<br>avours).(ac<br>Contains Bezocaine 15 mg & Isomalt ST- | 9 | Isomalt ST-M | 2571.00 mg | |||||||
| <br>M 2571<br>and Isom | <br>Mg. Net Content Benzocaine 13.245 Kgs<br>alt ST-M - 2270.172 Kgs.) | ||||||||||
| <br>R | |||||||||||
| 7 | Biomedic Oral Anesthetic Lozenges Sore Throat &<br>Nasal Congestion Relief Extra Strength Cherry ST<br>& NC RELEX Lozenges((Flavours Cherry / Honey<br>Lemon/ Other flavours) Each Lozenge Contains<br>Bezocaine 15 mg & Isomalt ST-M 2571 Mg. Net<br>Content Benzocaine 13.245 Kgs and Isomalt ST-M -<br>2270.172 Kgs.)7 | <br> <br> <br> <br> <br> <br>1 Number | 10 | Benzocaine | 15.30 mg | ||||||
| 11 | Isomalt ST-M | 2571.00 mg | |||||||||
| 8 | Atoma Sore Thro<br>Strength Lozenge | at & Nasal<br>s Cherry/H | Congest<br>oney & | ion Relief Extra<br>Lemon Flavour. | <br> <br>1 Number | 12 | Benzocaine | 15.30 mg | |||
| <br>Each Lozenge Co<br>ST-M 2700 Mg<br>Kgs and Isomalt | <br>ntains(Bez<br>. Net Con<br>ST-M - 227 | <br>ocaine 1<br>tent Ben<br>0.172 K | <br>5 mg & Isomalt<br>zocaine 13.245<br>gs.) | <br> <br> | 13 | Isomalt ST-M | 2700.00 mg | ||||
| <br>A concerned may take further necessary action as per above decision of NC. | |||||||||||
| C | ase No. | 173 / NC/3/MEET/Sep/202223/9 | |||||||||
| Case Status | Case Approved | ||||||||||
| Party Name | J B CHEMICALS AND PHARMACEUTICALS LIMITED | ||||||||||
| Meeting Number | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| Case No. | 173 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | J B CHEMICALS AND PHARMACEUTICALS LIMITED |
| Meeting Number | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
99
UDIN00236046AM23
| and Date | and Date | and Date | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HQ File Number | HQRNORM APPLY 00378226AM22 | ||||||||||
| RA File Number | 03AX04001471 AM22 | ||||||||||
| Licence No and | |||||||||||
| Date | 0311012326/07/03/2022 | ||||||||||
| Norms Committee | Decision: | ||||||||||
| The Committee co | nsidered the case as per agenda and taking cue from earlier decision for same export product / | ||||||||||
| <br>i i i | <br>iC/3/MEET/l/202122/4 15072021i d hii | ||||||||||
| mport tem n | eetng No.**NJu dated ..**aganst avance autorzaton No. | ||||||||||
| 0311002050 dated | 03.03.2021, it was decided to ratify adhoc n | orms under Para 4.07 of HBP Vol. I as per details | |||||||||
| given below or as a | pplied by the firm, whichever is less: | ||||||||||
| Sl. No. | Export p | roduct | Qty. | Sl. No. | Import items | Qty. | |||||
| 1 | |||||||||||
| Rinza sip | with Vitamin C (Flavours Orange/ | 1 Number | 1 | Caffeine Anhydrous Powder | 30.30 mg / | ||||||
| <br>Lemon/ Black Currant/ Other flavours)<br> | Sachet | <br>5 m sachet | |||||||||
| &(Rinza Sip (Flavours Orange/ Lemon/<br>Black currant/ Cranberr/ Hone Lemon/ | g | ||||||||||
| <br>Other flav | y y<br>ours). Each sachet of 5gm contains | ||||||||||
| <br>Caffeine | <br>Anhydrous Powder 30mg. Net | ||||||||||
| content<br> | of Caffeine Anhydrous Powder<br> | ||||||||||
| 923.64 K | s.) | ||||||||||
| 2 | Rinza Ta<br> | blets. Each tablet Contains Caffeine<br> | <br> <br>1 Number<br> | 2 | Caffeine Anhydrous Powder | 30.60 mg /<br> | |||||
| Anhydrou<br> | s Powder 30 mg and Paracetamol<br> | <br> <br>Tablet | 30 mg tablet | ||||||||
| BP 500<br>Anhydrou | mg.(Net Content of Caffeine<br>s<br>Powder<br>-<br>960<br>Kgs<br>and | <br> | |||||||||
| <br>Paracetam | <br> <br> <br> <br> <br> <br>ol BP- 16000 Kgs) | 3 | Paracetamol BP | 510 mg / | |||||||
| 500 mg tablet | |||||||||||
| 3 | |||||||||||
| Rinza Sip for Children (Flavours Raspberry/<br>other flavours). Each sachet of 3gm contains<br>Paracetamol BP - 280mg.(Net content- 576.92<br>Kgs.) | <br> <br> <br>1 Number<br>Sachet | 4 | Paracetamol BP | 282.80 mg /<br>3 gm sachet | |||||||
| R | A concerned may take fu | rther nec | essary ac | tion as per above decision of NC. | |||||||
| C | ase No. | 174 / NC | /3/MEE | T/Sep/202223/9 | |||||||
| C | ase Status | Case Approved | |||||||||
| P | arty Name | SMS PHARMACEUTICALS LIMITED | |||||||||
| M | eeting Number an | d Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | ||||||||
| H | Q Fil Nmbr | HQRNORM APPLY 00379575AM22 | |||||||||
| e ue | |||||||||||
| R | A File Number | 09AX04000173 AM22 | |||||||||
| L | icence No and Da | te | 0911002637/08/03/2022 |
| Case No. | 174 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | SMS PHARMACEUTICALS LIMITED |
| Meeting Number and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00379575AM22 |
| RA File Number | 09AX04000173 AM22 |
| Licence No and Date | 0911002637/08/03/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
100
UDIN00236046AM23
Norms Committee Decision:
The Committee considered the case as per agenda and taking cue from earlier decision for same export product / import item in Meeting No. NC/3/MEET/Aug/202223/6 dated 09.09.2022 against advance authorization No. 0911002507 dated 11.02.2022 , it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| SITAGLIPTIN<br>HYDROCHLORIDE | 1 kg | 1 | 2,4,5 TRIFLUOROPHENYLACETIC ACID | 1.146 kg |
| 2 | MELDRUM ACID | 0.88 kg | ||
| 3 | 3-(TERIFLUOROMETHYL)-5,6,7,8-TETRAHYDRI-<br>[1,2,4]<br>TRIAZOLO[4,3-a]<br>PYRAZINE<br>HYDROCHLORIDE | 0.75 kg | ||
| 4 | DI-TERTIARY BUTYL DICARBONATE (DIBOC) | 1.50 kg | ||
| 5 | TETRAHYDROFURAN | 1.50 kg | ||
| 6 | ISO PROPYL ALCOHOL | 5.50 kg | ||
| 7 | METHANOL | 3.12 kg | ||
| 8 | N-HEPTANE | 1.80 kg | ||
| 9 | METHYL DI CHLORIDE | 12.18 kg | ||
| 10 | TERTIARY BUTANOL (T-BUTANOL) | 1.78 kg |
| Case No. | 175 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | PI INDUSTRIES LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00379523AM22 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
101
UDIN00236046AM23
| RA File Number<br>13AX04000105 AM22 | ||||
|---|---|---|---|---|
| Licence No and<br>Date<br>1311001062/08/03/2022 | ||||
| Norms Committee Decision: | ||||
| The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP | ||||
| Vol. I as per details given below or as applied by the firm, whichever is less: | ||||
| Export product<br>Qty. | Sl. No. | Import items | Qty. | |
| CCIM Chemical Name: 4-<br>1 kg | 1 | p-methylacetophenone | 1.201 kg | |
| Chloro-5-p-tolylimidazole-2- | ||||
| carbonitrile | ||||
| 2 | Hydroxylamine sulfate | 3.53 kg | ||
| 3 | Glyoxal 40 % Min. | 1.352 kg | ||
| 4 | Dimethyl formamide | 2.50 kg | ||
| <br>RA concerned may take further necessary action as per above decision of NC |
| Case No. | 176 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | INTAS PHARMACEUTICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00379532AM22 |
| RA File Number | 08AX04000605 AM22 |
| Licence No and<br>Date | 0811004316/08/03/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No. | 177 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Approved |
| Party Name | ASCENT FINECHEM PRIVATE LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00379544AM22 |
| RA File Number | 08AX04000568 AM22 |
| Licence No and | 0811004319/08/03/2022 |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
102
UDIN00236046AM23
Date
Norms Committee Decision:
The Committee considered the case as per agenda and taking cue from earlier decision for same export product / import item in Meeting No. NC/3/MEET/Jun/202122/2 dated 02.07.2021 against advance authorization No. 0811001489 dated 14.05.2021 , it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:
| Export product | Qty. | Sl. No. | Import items | Qty. |
|---|---|---|---|---|
| N-(3-AMINOPROPYL) IMIDAZOLE | 1 kg | 1 | IMIDAZOLE | 0.68 kg |
| 2 | SODIUM METHOXIDE POWDER | 1.00 kg | ||
| 3 | ACRYLONITRILE | 0.466 kg |
| Case No. | Case No. | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | SUVEN PHARMACEUTICALS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00379551AM22 | |||||
| RA File Number | 09AX04000299 AM22 | |||||
| Licence No and<br>Date | 0911002631/08/03/2022 | |||||
| Norms Committee Decision:<br>The Committee considered case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP Vol.<br>I as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>L TERT LEUCINE<br>0.72 kg<br>2<br>ETHYL TRIFLUORO ACETATE<br>0.78 kg<br>3-METHYL-N-<br>(TRIFLUOROACETYL)-L-<br>VALINE(POWDER)<br>1 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| 3-METHYL-N-<br>(TRIFLUOROACETYL)-L-<br>VALINE(POWDER) | 1 kg | 1 | L TERT LEUCINE | 0.72 kg | ||
| 2 | ETHYL TRIFLUORO ACETATE | 0.78 kg |
| Case No. | Case No. | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 | 178 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|
| Case Status | Case Approved | |||||
| Party Name | SUVEN PHARMACEUTICALS LIMITED | |||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||
| HQ File Number | HQRNORM APPLY 00379551AM22 | |||||
| RA File Number | 09AX04000299 AM22 | |||||
| Licence No and<br>Date | 0911002631/08/03/2022 | |||||
| Norms Committee Decision:<br>The Committee considered case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP Vol.<br>I as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>L TERT LEUCINE<br>0.72 kg<br>2<br>ETHYL TRIFLUORO ACETATE<br>0.78 kg<br>3-METHYL-N-<br>(TRIFLUOROACETYL)-L-<br>VALINE(POWDER)<br>1 kg | ||||||
| Export product | Qty. | Sl. No. | Import items | Qty. | ||
| 3-METHYL-N-<br>(TRIFLUOROACETYL)-L-<br>VALINE(POWDER) | 1 kg | 1 | L TERT LEUCINE | 0.72 kg | ||
| 2 | ETHYL TRIFLUORO ACETATE | 0.78 kg |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
103
UDIN00236046AM23
3 HEPTANE 3.88 kg
| Case No. | 179 / NC/3/MEET/Sep/202223/9 |
|---|---|
| Case Status | Case Deferred |
| Party Name | ALEMBIC PHARMACEUTICALS LIMITED |
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 |
| HQ File Number | HQRNORM APPLY 00380949AM22 |
| RA File Number | 34AX04000157 AM22 |
| Licence No and<br>Date | 3411001935/09/03/2022 |
| Norms Committee Decision: | |
| Deferred for comments of TE. |
| Case No. | Case No. | Case No. | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 | 179 / NC/3/MEET/Sep/202223/9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case Status | Case Deferred | |||||||||||
| Party Name | ALEMBIC PHARMACEUTICALS LIMITED | |||||||||||
| Meeting Number<br>and Date | NC/ 3/ MEET/ Sep/ 202223/ 9 and 07/10/2022 | |||||||||||
| HQ File Number | HQRNORM APPLY 00380949AM22 | |||||||||||
| RA File Number | 34AX04000157 AM22 | |||||||||||
| Licence No and<br>Date | 3411001935/09/03/2022 | |||||||||||
| Norms Committee Decision:<br>Deferred for comments of TE. | ||||||||||||
| Case No. | 180 / NC/3/MEET/Sep/202223/9 | |||||||||||
| Case Status | Case Approved | |||||||||||
| Party Name | SUN PHARMACEUTICAL INDUSTRIES LIMITED | |||||||||||
| Meeting Number | NC/ 3/ MEET/ Se/ 202223/ 9 and 07/10/2022 | |||||||||||
| and Date | p | |||||||||||
| HQ File Number | HQRNORM APPLY 00380993AM22 | |||||||||||
| RA File Number | 05AX04001235 AM22 | |||||||||||
| Licence No and | 0511010844/09/03/2022 | |||||||||||
| Date | ||||||||||||
| Norms Committee | Decision: | |||||||||||
| The Committee considered the case as per agenda and taking cue from earlier decision for same export product /<br>import item in Meeting No.NC/3/MEET/Oct/202122/9 dated 15.10.2021against advance authorization No.<br>0510414338 dated 05.06.2020, it was decided to ratify adhoc norms under Para 4.07 of HBP Vol. I as per details<br>given below or as applied by the firm, whichever is less:<br>Sl. No. Export product<br>Qty.<br>Sl. No. Import items<br>Qty.<br>1<br>Azelastine Hydrochloride Nasal Solution<br>(Nasal Spray) 0.1% 30ML. (Each Solution /<br>Spray<br>contains<br>30<br>Mg<br>Azelastine<br>Hydrochloride) (Equivalent to 52.500 Kg of<br>bulk drug))<br>1750000<br>Number<br>1<br>Azelastine<br>Hydrochloride<br>48.909 kg | ||||||||||||
| Sl N | Et dt | t | Sl N | It it | t | |||||||
| . o. | xpor prouc | Qy. | . o. | mpor ems | Qy. | |||||||
| 1 | Alti H | dhli | N | l Slti | <br>1750000 | 1 | Alti | 48909 k | ||||
| zeasne y<br>(Nasal Spray)<br>Spray<br>contai<br>Hydrochloride)<br>bulk drug)) | rocor<br>0.1% 30M<br>ns<br>30<br>(Equival | e as<br>L. (Eac<br>Mg<br>ent to 5 | ouon<br>h Solution /<br>Azelastine<br>2.500 Kg of | <br> <br> <br> <br><br>Number | zeasne<br>Hydrochloride | . g | ||||||
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
104
UDIN00236046AM23
| 2 | Azelastine<br>Hydrochloride<br>Ophthalmic | <br>7500000 | 1 | Azelastine | 22.950 kg |
|---|---|---|---|---|---|
| Solution<br>0.05%<br>6ML.<br>(Each<br>Solution | Hydrochloride | ||||
| contains 3 Mg Azelastine Hydrochloride) | <br>Number | ||||
| (Equivalent to 22.500 Kg of bulk drug) (Total | |||||
| Net Contents 75.000 Kg) ) |
Digitally Signed. Name: Ajay Kumar( Deputy Director ) Date: 19-Oct-2022 12:55:42 Reason: AJAY.DHIMAN88@GOV.IN Location: DGFT(HQ)
105
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis has been generated for this document yet.